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Abstract 
The aims were to perform a bioinformatic-statistical analysis of CRISPR-Cas- and R-M 
systems in a diverse whole genome sequenced K. pneumoniae population, and their 
correlations to virulence score and AMR -/ plasmid content. The strains (n=999) consisted of 
Norwegian fecal carrier (n=484) and clinical (NORM; ESBL and non-ESBL producing) 
(n=414), and national-international clinical ST307 strains (n=101).  
Structural complete CRISPR-Cas systems were found in 26% of the strains; carrier (30%), 
NORM non-ESBL (26%), NORM-ESBL (29%), and ST307 (0%). R-M systems were found 
in 48% of the strains; carrier (43%), NORM (44%) and ST307 (90%). The presence of 
CRISPR-Cas- and R-M systems seems to be equally distributed between carrier and clinical 
strains. The systems distributions had ST-specific profiles as illustrated with the ST307 
strains. 
Some significant cross-population correlations were observed between the presence/absence 
of CRISPR-Cas-/R-M systems in terms of MGE acquisition, represented by virulence score, 
AMR - and plasmid content. CRISPR-Cas systems strains were associated with a higher 
virulence score and a lower AMR-/plasmid load. The R-M systems strains were associated 
with lower virulence score and a higher AMR-/plasmid load.  
Future studies should include analysis of CRISPR spacer content and specificity, overall 
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1 Klebsiella pneumoniae - a global opportunistic 
multidrug resistant pathogen 
The first known description of K. pneumoniae was done by Carl Friendländer documenting the 
bacteria as a cause of pneumonia in 1882 (1)(2). Since then K. pneumoniae has been established 
as a major opportunistic pathogen causing infections primarily in hospitalised patients (1). The 
most common infections caused by K. pneumoniae are urinary tract infections (UTIs), 
bloodstream infections (BSIs) and pneumonia (3)(4)(5)(6).  
Due to the ability of K. pneumoniae to acquire antimicrobial resistance (AMR) genes and 
develop multidrug resistance (MDR), the World Health Organization (WHO) has now 
acknowledged K. pneumoniae on their critical pathogen priority list “Global priority list of 
antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics” 
(7). Moreover, K. pneumoniae is also included in the ESKAPE pathogens (Enterococcus 
faecium, Staphylococcus aureus, K. pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa and Enterobacter) that is known to cause difficult-to-treat MDR and/or 
hypervirulent nosocomial infections (1)(3).  
In addition to its ability to acquire MDR, K. pneumoniae has also the capability to disseminate 
AMR genes within and across species through horizontal gene transfer (HGT) (8). However, 
there are mechanisms limiting the acquisition and adaptation of foreign DNA protecting the 
host from unwanted DNA. These mechanisms include Restriction- Modification (R-M)- and 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)- CRISPR associated 
proteins (Cas) systems (9)(10). Previous publications indicate that the CRISPR-Cas systems 
are not equally distributed in K. pneumoniae populations, but highly associated to certain ST 
types (11). A recent review on the population genomics of K. pneumoniae underscores 
knowledge gaps in understanding the potential relatedness of CRISPR-Cas and R-M-systems 
on plasmid and phage diversity (1). The association between the presence/absence of R-M- and 
CRISPR-Cas systems and the presence/absence of defined accessory genome elements 
(plasmids, AMR- and virulence genes) in different K. pneumoniae strain collections is the topic 
of this thesis.  
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1.1 Relevant characteristics of Klebsiella pneumoniae 
K. pneumoniae is a rod-shaped, gram-negative, facultative anaerobic, non-spore forming 
opportunistic bacteria (3). In humans, K. pneumoniae is mostly found as part of the normal 
mucosal flora, particularly in the lower intestines (3).  
1.1.1 Taxonomy 
Klebsiella pneumoniae forms a group of bacteria within the order of ‘Enterobacteriales’ 
(synonym: Enterobacterales ord. nov) consisting of seven families; Enterobacteriaceae, 
Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. 
nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. (12). The Klebsiella genus is 
located within the family of Enterobacteriaceae (12). The order includes 60 different genera 
(by 2016) and over 250 species (12). However, most of the species is within the family 
Enterobacteriaceae, resulting in a highly taxonomically diverse family (12).  
The K. pneumoniae species complex (KpSC) includes seven phylogroups (Kp1-Kp7); K. 
pneumoniae sensu stricto (Kp1), K. quasipneumoniae subsp. quasipneumoniae (Kp2) and 
subsp. similipneumoniae (Kp4), K. variicola subsp. variicola (Kp3) and subsp. tropica (Kp5), 
“K. quasivariicola” (Kp6), and K. africana (Kp7) (13). Kp5 and Kp7 do not have a formal 
taxonomic status yet (1). The seven phylogroups (species) are closely related and share 95-96% 
average nucleotide identity (1). There are significant gaps in knowledge concerning the ecology 
of K. penumoniae phylogroups, and their main reservoirs and distributions may be distinct (14). 
In this study, K. pneumoniae sensu stricto, referred as K. pneumoniae will be the main focus as 
the dominant species associated with infections in humans (13).  
It is a challenge in the clinical microbiology laboratory to phenotypically distinguish 
between the seven phylogroups (1)(13). Thus, most strains will technically be identified as 
KpSC (1)(13). In the clinical setting, K. pneumoniae sensu stricto is the most frequent identified 
species by ~85% (1).  
1.1.2 KpSC ecology and distribution  
In brief, KpSC is not only found in humans, but also broadly in nature. The bacteria has been 
associated with plants, water, soil and a variety of animals (1)(3)(15). Spread of the bacteria 
itself, can therefore happen across many niches (3). However, the extent of transmission and 
the lines of dissemination between the different reservoirs need to be further examined (15). 
We also lack knowledge on the occurrence, relative abundance and characteristics of KpSC in 
different environments due to the absence of systematic studies (1).  
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The faecal carrier rate in humans varies between geographical locations and differences in study 
populations (8). Human faecal colonisation rates for K. pneumoniae have been reported to range 
from 6% in one Australian study, up to 62% in healthy Chinese adults and up to 88% in the 
Chinese population in Malaysia (16)(17). The culture-based  KpSC detection in the seventh 
Tromsø population study (T7) in 2015-2016 performed in community based adults (≥ 40 years 
n=3000), revealed an overall faecal carrier rate of 16,5% with a relative abundance of K. 
pneumoniae sensu stricto (61%), K. variicola (28%) K. quasipnemoniae subsp. 
quasipneumoniae (7%) and K. quasipneumoniae subsp. similipneumoniae (4%)(18).   
Pangenome studies have revealed a large genetic diversity within KpSC and raises the question 
of what gene repertoire are associated with the dissimilar locations (1)(19). A metabolic 
profiling study of various clonal lineages within KpSC has revealed a highly diverse set of 
biochemical properties for carbon and nitrogen metabolic capacities that could contribute to 
broad ecologic distribution of KpSC (19). In the same study, core metabolism features 
suggested an adaption to plant associated environments (19).   
1.1.3 K. pneumoniae genomics and population structure 
K. pneumoniae possesses a large and diverse 
genome (3). The genome has in average ~5-6 
Mbp and ~5000-6000 protein coding genes (1). 
In comparison the Escherichia coli encompass 
~5,1 Mbp and ~4915 protein coding genes 
(3)(8). The core genome consists of ~1700 
genes that are present in all strains regulating 
basic functions for survival in different 
environments (1)(3)(8). In addition, K. 
pneumoniae host ~3300-4300 accessory genes 
that varies between strains illustrating a large 
adaptive capacity (Figure 1) (1)(3)(8). This 
results in a diverse pangenome (core genome + 
all accessory genes detected in various K. pneumoniae strains) emphasizing a high capacity for 
horizontal gene transfer (HGT), including chromosomal recombination, plasmids and 
bacteriophages (3)(8). In the latest genomic review of K. pneumoniae it was estimated that the 






Pangenome of Klebsiella 
pneumoniae
Core genes Accessory genes
Figure 1: Pangenome of Klebsiella pneumoniae and its 
average distribution between core genes and accessory 
genes (1)(3)(8). In the example, the pangenome was set at a 
total 5Mbp 
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There are 100s of independent phylogenetic lineages or “clones” in K. pneumoniae based on 
core genome analyses (8). They only differ by ~0,5% nucleotide divergence (1)(8). A clone is 
genetically defined as a group of genetically closely related strains sharing a recent common 
ancestry of the genome (1)(20). Clonal groups (CG) or clones of K. pneumoniae are defined by 
a core genome multi locus sequence typing (cgMLST) scheme that consists of 694 different 
alleles and/or by the traditional seven core-genes MLST system (21)(22). K. pneumoniae 
cgMLST CGs are a groups of cgMLST profiles having <100/694 allelic mismatches (i.e., 
14,4% of the 694 alleles) with at least 1 other member of the group (22). The low level of 
genomic diversity among K. pneumoniae strains as defined by traditional MLST classification 
has made it difficult to line up boundaries between clones (21). However, the nearly 700 allelic 
cgMLST system provide a 100x more sequence information than the seven-gene MLST 
(21)(22). Clones can also be separated by looking into the accessory genome (8).  
The diverse ST types may possess differences in pathogenicity and some are spreading 
globally (2). Some clones have been more associated with MDR and others with hypervirulence 
causing serious community acquired infections (CAI) (3)(8). It is today still not fully 
understood why this distinction occurs, but it might be connected to the physical availability of 
either MDR or hypervirulence in the specific niche, lower fitness costs for some ST carrying 
plasmids, antibiotic induced pressure or possibly the absence/presence of  systems restricting 
HGT (3)(8)(15)(23).  
MDR clones can be defined as resistant to ≥3 antimicrobial classes in addition to their intrinsic 
resistance to ampicillin (1)(24). The presence of MDR is favourable in hospital environments 
where the bacteria may need an antibiotic resistant phenotype for its survival (1)(3)(15). Some 
MDR-phenotypes like those expressing extended-spectrum β-lactamases (ESBLs) or 
carbapenamases have been shown to be spreading globally causing hospital outbreaks and are 
of particular concern (1)(3). Local (25) and global comparative genomic studies (3) of K. 
pneumoniae have revealed a diversity of MDR-clones and some distinct successful epidemic 
clones that have become defined as “global MDR clones”, including CGs 258, 15, 20, 29, 37, 
101, 147, and 307 (1)(5)(26).  
Hypervirulent clones have mostly been reported spreading from Taiwan and Southeast Asia 
since the mid-1980s and pose a concern because of their ability to cause serious CAIs (2)(27). 
As opposed to MDR-clones, hypervirulent clones are dominated by a limited number of CGs 
(1). It is of great clinical concern that recent research have documented convergence of MDR 
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and virulence at the strain level (1). The mechanisms involved in convergence have recently 
been reviewed (1) and seem to include the acquisition of plasmids encoding virulence factors 
(virulence plasmids) or hybrid AMR-virulence plasmids by MDR clones (1)(8). Global MDR- 
and hypervirulent clones are named high-risk clones. 
Nosocomial infections in humans have often been associated with high-risk clonal types like 
CG23, CG25, CG65 (including ST65 and ST375), CG66, CG86, ST258 and the more recent 
ST307 (1). The situation is dynamic, and in the last 5 years the high-risk ST307 clone has 
displayed a significant increased prevalence (26). ST307 is also represented by Klebsiella 
pneumoniae carbapenamase (KPC) producing strains emerging from the globally disseminated 
ESBL CTX-M -producing parental strain (26). This CG is associated with frequent nosocomial 
outbreaks caused by  MDR phenotypes (1)(8). Clinically, patients infected with KPC producing 
ST307 displayed over 50% mortality and longer hospital stay, compared to patients infected 
with other strains (26).  
1.1.4 Antimicrobial resistance and development of MDR  
K. pneumoniae is well known for the ability to develop and spread AMR genes through HGT 
within and across species (8). This is an important feature in the development of MDR lineages  
such as ST258 and ST307 (8). In Europe hospital acquired infections (HAIs) like the high-risk 
MDR-associated STs, including ST11, ST15 and ST258, are seen frequently (1). In addition to 
these ST types, ST70 and ST323 alongside CG20 (CG17), CG29, CG37, CG147, CG101 
(CG43) and MDR- CG307 are most often observed causing nosocomial outbreaks (1). 
By 2018 over 400 AMR genes had been identified in available  genomes of K. pneumoniae, the 
majority being plasmid borne (3). In the latest population genomics review of K. pneumoniae, 
several hundreds of distinct acquired AMR alleles are referred (1).  
AMR-genes in K. pneumoniae can be divided into intrinsic and acquired determinants (1). K. 
pneumoniae species complex (KpSC) carry intrinsic class A β-lactamase genes (blaSHV in K. 
pneumoniae sensu stricto, blaLEN in K. variicola, blaOKP in K.quasipneumoniae) that confer 
clinical resistance to penicillins including ampicillin and piperacillin (1). Moreover, oqxAB and 
fosA are core genes in K. pneumoniae that mediate reduced susceptibility, but not clinical 
resistance, to fluoroquinolones or fosfomycin, respectively (1)(3)(28)(29). There is also 
numerous core genes participating in AMR development by point mutations increasing 
resistance, particularly genes associated with lipopolysaccharide (LPS) production and efflux 
or membrane permeability (1).  
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The acquired AMR alleles can be grouped by which antibiotic drug class they might affect 
using different bioinformatic tools. The most clinically relevant classes of antibiotics in the 
treatment of K. pneumoniae infections include aminoglycosides, β -lactams (e.g. 
cephalosporins and carbapenems), β-lactam β-lactamase inhibitor combinations (e. g 
piperacillin-tazobactam and ceftazidime-avibactam), fosfomycin, fluoroquinolones, 
polymyxins (colisitin), sulphonamides, trimethoprim and tigecycline (1)(3)(28)(29). A recent 
review have summarized studies that have explored the distribution of acquired AMR genes in 
different K. pneumoniae populations (1). The review revealed a bimodal distribution 
represented by global MDR clones with a high genetic AMR load affecting a number of drug 
classes (≥6), in contrast to hypervirulent clones hardly carrying any acquired AMR-
determinants at all. Several factors that could contribute to the irregular distribution of AMR 
between different genetic lineages, including differences in host plasmid maintenance 
mechanisms, have been suggested (1). The spread and distribution of β -lactamase-genes 
encoding ESBL are of particular concern and will be discussed further.  
ESBL producing K. pneumoniae. ESBL mediate resistance to the oxyimino-cephalosporins 
(cefotaxime, ceftazidime, ceftriaxone and cefepime) and monobactams (aztreonam) (30).  
ESBLs are classified in different ways, but for this study the Giske et al. definition will be 
utilized (24). This classification divides ESBLs into three main groups; ESBLA, ESBLM and 
ESBLCARBA-, all acquired by HGT (6)(31). The ESBLA encoding genes includes blaCTX-M, and 
some allelic variants of blaSHV and blaTEM (6)(31). ESBLA type β -lactamases hydrolyses all 
penicillin, monobactams and cephalosporins, leaving only cephamycin, carbapenems and 
penicillin + β -lactam inhibitors as potential useful antimicrobial agents (6)(31). The ESBLM 
group is a diverse group of β -lactamases where the plasmid-mediated AmpCs are most 
prevalent, including CMY and DHA (6)(31). ESBLM hydrolyse most cephalosporins, all 
monobactams and penicillins, leaving only carbapenems and 4th generation cephalosporins to 
work. Most ESBLCARBA enzymes (except members of  the OXA-family) hydrolyse all β -
lactams, including the carbapenems and include Ambler class B metallo β-lactamases (ex. VIM 
and NDM), class A serine (ex. KPC) and class D (ex. OXA-48 family) carbapenamases (6)(31).  
The ESBL-genes are most often located on plasmids, often carrying additional AMR-genes 
towards important commonly used antibiotics such as aminoglycosides, trimethoprim-
sulfamethoxazole and fluoroquinolones (6)(32). This contributes to development of MDR, 
defined as acquired resistance to three or more different antibiotic classes (33). Transmission 
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of ESBL -producing bacteria (Enterobacteriaceae) most often occur through faecal-oral 
contamination in the community, but also involves various transmission lines in hospital-
environments (32).  
The historical acquisition of different classes of ESBL-genes in K. pneumoniae is outlined in 
Figure 2 (3). Throughout 1980-1990s ESBL-variants of TEM and SHV emerged at least partly 
as a response to the use of third generation cephalosporins (3)(30). In the 1990s the CTX-M-
type ESBLs started to dominate and also causing CAIs with CTX-M producing E. coli (28)(30). 
The CTX-M are divided into five groups; 1, 2, 8, 9 and 25 based on amino acid homology (34). 
CTX-M-14 and CTX-M-15, have been the most frequently appearing ESBLs in worldwide 
surveillance studies (6)(28)(35)(36). Some CTX-Ms are mostly bond to geographical locations 
(6)(28)(35)(36).  
The plasmid mediated genes qnrA and qnrB mediating resistance to quinolone were later 
detected and has disseminated worldwide in the high-risk MDR-clones including ST258 
(3)(37). The OXA, CTX-M-14/15, CMY-1, NDM-1 and KPC β -lactamases have increased 
significantly globally since 2005 (3). The mcr-1 gene is often plasmid borne and mediates 
colistin resistance by modifying LPS as a response to colistin exposure (2). 
1.1.5 Pathogenicity 
Pathogenicity is defined as the ability to cause disease (38).  A virulence factor by definition 
enhances pathogenicity (38). Virulence factors can be either intrinsic or acquired (38). 
Intrinsic virulence factors are encoded by loci present in all K. pneumoniae  making it 
generally capable of causing infections (1). K. pneumoniae is defined as an opportunistic 
pathogen in general, but some strains have acquired more virulence factors making them a 
true pathogen also causing CAIs (1). See Table 1 for an overview of the most common and 
validated virulence factors.  
Figure 2: The timeline of clinically important classes of AMR-genes detected in Klebsiella pneumoniae from 1970 
to 2020 (3)(27). The picture is modified from reference (3). 
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Table 1: Important intrinsic and acquired virulence factors in K. penumoniae 









K1, K2 & K5 
especially  
Increased survival 
in serum and 
tissue 
 
Antiphagocytic effect preventing phagocytosis 
and intracellular killing by macrophages and 
neutrophils (2)(39). The lack of specific 
mannose residue repeats recognised by the 
immune system of the host (2)(39). Slightly 
increased release of reactive oxygen species by 
neutrophils (2)(39). Host-specific 
monosaccharide sialic acid on the surface 




O1, O2 & O3 
especially 
Vascular survival 
by altering outer 
membrane 
properties? 
Little to no documentation, just assumptions 
that the biosynthesis associated O3 might be 
associated with survival in blood (39).  
Decreased local proliferation and dissemination 
suppressing the inflammatory response (40) 
Regulator of the 
mucoid phenotype 
A gene (rmpA) 
RmpA and rmpA2 Hypermucoid 
phenotype 
Increasing capsule production creating a 
hypermucoid “sticky” bacteria (8)(39)  






in the vascular 




Enhances iron sequestration and thus promotes 
survival in the vascular system (icu, iro and 
ent)(8). Ybt provides an iron scavenging system 
and has the ability to escape Lcn-2 binding and 
avoids the inflammatory response enhancing 
survival in the spleen (41). It can also bind 
other heavy metals avoiding toxicity (41). Iro 
modifies enterobactin to escape Lcn2 binding 
(41). Icu scavenge iron from transferrin (41) 
Colibactin 
genotoxin 






Eukaryotic cell death by DNA damage and 
promotes invasion from the intestine to the 
vascular system (1)(8)(39). 
Fimbriae Type 1 & 3 Increase 
colonization 
Increases biofilm production and thus 
contribute to colonization (1). Adherence to 




gly Increased survival 
in the urinary 
system 
Higher survival in nutrient deficient 
environments (26) 
 
Intrinsic virulence factors found in all K. pneumoniae include enterobactin (ent), fimbriae 
(fim and  mrk), lipopolysaccharide LPS (O-antigen) and capsular polysaccharide (K-antigen) 
(1)(39). These intrinsic factors comprise ~10% of the genome coding capasity and can be found 
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in many variations (1). Combinations of virulence factors may result in increased pathogenicity 
(8)(39). These combinations are often found in certain CG types, hypervirulent clones (e.g. 
CG23, CG65 an CG86 (1)(8)(39).  
Previously K. pneumoniae has been serotyped using antisera distinguishing between different 
surface polysaccharides, K- and O- antigens (39). In total, there are at least 78 capsular 
serotypes for K. pneumoniae, but only K1 and K2 are strongly associated with hypervirulence 
and a hypermucoid phenotype (2)(8)(39). However, the K5 variant has also been associated 
with liver abscesses, but is not commonly seen (1). O serotype diversity is also connected to 
K1/K2 providing further mechanisms to invade the host (2). However, the O-antigen is less 
understood and today there are mostly assumptions that it contributes to increased survival in 
the vascular system (39). 
Acquired virulence factors enhance pathogenicity (1). Colibactin endotoxin was formerly 
only seen in E. coli, but has emerged in ~10% of K. pneumoniae and is associated with liver 
abscess clones (1). Regulatory genes like rmpA and rmpA2 are associated with a hypermucoid 
phenotype as well  as other siderophore gene clusters playing important roles (5)(37). The 
combination of K1- or K2 capsule types and the rmpA genes has shown a proven ability to 
enhance the pathogenicity (1)(2)(39).  
Acquired siderophores have some similarities, but also mechanistic differences, and may 
therefore have an additive effect on pathogenicity in cooperation with the intrinsic Enterobactin 
(1). They are associated with hypervirulent strains causing invasive CAIs (1). Despite the many 
siderophores and their variants, aerobactin has been proven to play a greater role for 
hypervirulence and is the most prevalent acquired siderophore (2). Aerobactin and salmochelin 
is often found co-located with the rmpA/rmpA2 genes on virulence plasmids (1)(2)(8). 
However, the prevalence of these loci is still low in the K. pneumoniae population by only 
<10% (8).  
1.1.6 Clinical perspectives 
K. pneumoniae is an opportunistic pathogen most often associated with HAIs in 
immunosuppressed patients (1). UTIs, BSIs and pneumoniae are the classical infections 
(3)(4)(5)(6). K. pneumoniae thrive in the hospital environments, supported by the large 
genomic space available for adaptation, including AMR-genes and virulence determinants 
favouring survival within the antibiotic-exposed hospital environment (8)(26). Spread of K. 
pneumoniae can happen “silently” between patients or through health care workers and medical 
 
Page 16 of 109 
equipment (3)(26)(15)(42)(43). Several studies have shown that the origin of the human K. 
pneumoniae infections is the patient’s own gut microbiome (43). Studies have shown an overall 
prevalence of HAIs in Europe around 7 per 100 patients, increasing by the duration of patient-
days in hospitals (15). Factors contributing to the prevalence of HAIs are access to resources, 
knowledge based hospital services, antibiotic restrictions and good basic hygienic practices 
(15).  The situation in Scandinavia, compared to other European countries, displays a lower 
prevalence of nosocomial infections caused by MDR K. pneumonia (15). Previous HAIs was 
often linked to certain CGs with a MDR-phenotype, but recently CGs with a combined MDR- 
and hypervirulent phenotype have emerged, posing a clinical threat (1)(8). 
2 Evolution of the bacterial genome- drivers and 
restrictions 
Evolution of the bacterial genome is essential for survival and adaptation to new niches and 
selective pressures (44). There are many ways to achieve evolutionary adaptation including 
mutations and acquisition of new genetic material (44). However, unlimited access to new DNA 
is absolutely not in favour of the bacteria because it increases the fitness costs and may even be 
detrimental when it comes to bacteriophage infections (45). Therefore, mechanisms restricting, 
protecting and reviewing both new and already acquired genetic components are needed (44). 
The mechanisms are supposedly many, but the most studied and probably important ones are 
the CRISPR-Cas- and the R-M systems (9)(10). Although these system has been examined for 
decades, they are yet to be fully understood (46).  
2.1 Horizontal gene transfer (HGT) contributing to evolution 
HGT is the major driver for natural genetic diversity, evolution and bacterial survival including 
the dissemination of AMR genes, evolution of gene clusters encoding biochemical pathways 
and exchange of pathogenicity factors (46). Bacteria can share genomic elements through both 
HGT and vertical gene transfer (VGT), but for this study we will focus on HGT (20). HGT can 
be carried out in three principal mechanisms; transformation (uptake of free DNA), conjugation 
(cell-contact-mediated-transfer) and transduction (phage-mediated transfer) (20).  
Transformation is a mechanism for bacterial uptake of free naked DNA from the environment 
shared by some bacterial species (44). Starvation, difficult growth conditions, low nutrient 
access or cell density induces a state of competence by expression of ~20-50 proteins making 
the bacteria accessible for naked DNA uptake (44). This process is not fully understood, but 
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the main mechanisms are recognized (44). The extracellular DNA often originates from 
decomposing cells, disrupted cells or viral particles (44). Translocation across the inner 
membrane is sometimes a more regulated process only allowing a certain length (44). If the 
sequence is highly similar to the receiving host genome, then the regions can initiate DNA 
pairing and exchange strands (44). The success rate of this process is highly varying between 
bacterial species and in general lower than other HGT mechanisms (44).  
Plasmid transfer between bacteria occurs through bacterial conjugation (20). K. 
pneumoniae often harbours plasmids ranging in size containing a variety of accessory functions 
(47). Plasmids are extrachromosomal genetic elements, most often double-stranded (ds)DNA 
packages that can contain several core (encoding replication, mobility and potential transfer) 
and accessory genetic components varying in size (48). Usually, the size varies from a few kb 
and up to hundreds of kb (48).  Current classification schemes use the backbone (core) loci for 
replication (replicon typing) or plasmid mobility (MOB typing) (49). Plasmids are easily shared 
through HGT, where the recipient can get access to essential mechanisms for survival in the 
environment (20)(47). However, fitness costs often increase by acquiring plasmids (45).  
The conjugation process can be described by plasmid transfer, although only some plasmids 
are conjugative (i.e. encode transfer functions) (20). Others requires the help of another plasmid 
(helper-plasmids encoding conjugative functions) or other conjugative elements ( i.e. 
conjugative transposons or integrative conjugative elements -ICE)(20). Conjugation is carried 
out by direct cell-to-cell contact (donor and recipient),by forming a relaxosome bridge, 
typically initiated by a pilus from the donor (20). This initiates synthesis of 
helicase/endonuclease nicking the donor DNA (20). Then the relaxosome forms a complex with 
other fertility factor proteins and unwinds the donors dsDNA before the transfer process can 
initiate (20). The single stranded (ss)DNA is transferred as a part of  DNA-protein complex and 
DNA polymerase III is recruited for replication in the donor cell, pushing the rest of the strand 
through to the recipient (20). In the recipient cell, the strand quickly circulates and replicates 
(20). The conjugation complex falls apart and the membranes seal, leaving both cells as 
competent donors (20).  
Bacteriophages possess the ability to move chromosomal DNA from a donor to another 
bacteria through transduction (20).  Transduction has been divided into generalized- (the 
transfer of any gene) and specialized (transfer of only a few closely linked genes) transduction 
(20). Generalized transduction happens when the bacteriophage (phage) infects a cell, injects 
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viral DNA and makes subunit components for phage construction (20). Packing of phage- 
and/or host DNA into capsids and attachment to tails completes the formation of new phages 
(20). They are released through cell lysis and the new phages can inject a new host with DNA 
where it might initiative a new round of replication or recombine into the chromosome and 
create a lysogenic stage (20). Specialized transduction happens when improper excision of 
integrated phage DNA from the bacterial host chromosome takes place (20). This event is rare 
and results in the lack of a few viral genes where the host genes is inserted (20). Some of the 
phage can replicate themselves, but others heavily rely on a helper-phage harbouring the 
missing gene products (20). The product of this specialized transduction is a hybrid DNA also 
providing the receiving host with diploid host genes that may be a substrate for new 
recombination events (20).  
2.2 CRISPR-Cas systems restricting evolution? 
Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR) coupled with the 
CRISPR associated (Cas) proteins (CRISPR-Cas) are an adaptive immune system of 
prokaryotes protecting against foreign DNA (50). The repeated sequences of CRISPR-loci were 
first described in 1987, but their functional role as part of DNA-memory storage and a specific 
immune system was experimentally not proven until 2007 (50). Today this system provides a 
target for functional research for genetic engineering revealing many opportunities (27)(50). 
However, many CRISPR-Cas functions in the evolution of prokaryotes and their molecular 
mechanisms still remain unknown (50). Several studies have suggested that CRISPR-Cas 
systems also could be involved in biofilm formation, colonization and virulence regulation 
(11)(51).  
A complex functional pathway has allowed the system to generate recognition of invading 
genetic elements through an evolving library of spacer sequences, generating memory. The 
system regulates exchange of genetic elements through HGT, induce removal of unnecessary 
genetic elements, regulates plasmid incorporation and virulence uptake in the bacteria 
harbouring these systems (11).  
2.2.1 Structure, classification and basic characteristics 
The CRISPR-loci, Cas proteins and CRISPR RNAs (crRNAs) are the basic functional parts of 
the system (51). A classic CRISPR-Cas locus consists of Cas genes, a leader sequence and a 
CRISPR array (Figure 3)(9)(10)(51). The CRISPR array consists of almost identical short direct 
repeats of ~21-47 nucleotides separating the spacers containing 20-60 nucleotides of 
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hypervariable sequences acquired from MGEs the system has been exposed to (45)(52). This 
sequence specific “memory” of the spacers, provides recognition of the same invading elements 
leading to destruction and thus preventing infection through the pathway (27)(45). The leader 
sequence is normally an AT-rich region usually ~100-500bp that possesses the ability to 
polarize potential new spacers using the proto-spacer adjacent motif (PAM) promoting 
transcription (27)(45). The Cas proteins vary in numbers and functions between CRISPR-Cas 
systems (27)(53)(54). The Cas proteins performs different enzymatic functions including 
nuclease, helicase or polymerase activity (11). Usually, the Cas genes are located close to the 
CRISPR arrays (10). 
 
Figure 3: Structure of the CRISPR- Cas system displaying the Cas genes, the leader sequence, repeat spacer-array and the 
typical genes found upstream and downstream to the system. This figure was made using the SimpleSynteny output displaying 
a standard Class 1 type I-E system. 
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The Cas proteins and their functional pathways are most often divided into three 
functional steps; the adaptation (integration of spacers), expression (crRNA processing, 
maturation and target binding) and interference stage (target recognition and 
cleavage)(54)(55). Figure 4 displays the 
functional pathway for CRISPR-Cas type I 
systems. CRISPR- Cas systems in Klebsiella 
needs to be further studied, but so far KpSC is 
only found harbouring type I-E, I-V, I-F and the 
newly documented I-E* system (51).  
The adaptation stage starts by recognition of the 
protospacer region by PAMs (27)(53). The 
protospacers are foreign DNA incorporated into 
the CRISPR arrays as small memory cassettes for 
future recognition of the same invading elements 
(54). The genetic fragments can be from DNA 
donors such as bacteriophages and plasmids (27). 
Some systems also have the ability to include 
RNA precursors after reverse transcription (27). 
The PAMs makes bonds with the adaptation Cas 
complex possible (27)(53). The adaptation Cas 
complex is formed by Cas1 and Cas2, for most 
known systems, which is necessary for spacer 
insertion (54). The specific mechanism and 
assembly of the adaptation Cas complex remains 
unknown (27)(53).  
In the expression stage the temporarily spacers (protospacers) are transcribed from the leader, 
downstream to the CRISPR array and a multi-spacer pre-crRNA is formed (27)(54). Further 
the pre-crRNA is processed into a single spacer crRNA by either Cas9 (single multidomain 
protein) or a multi-subunit complex (for type I-E: Cas8 (CasA), Cas11 (CasB), Cas7, Cas5 and 
Cas6) forming the crRNA effector complex (type I systems), resulting in a more permanent 
mature spacer (27)(54)(56). Consequently, crRNA is processed into a shorter sequence of ~57 
nucleotides by an endonuclease subunit of the multi-subunit effector complex (type I system) 
Figure 4: The functional pathway for CRISPR-Cas type I 
systems through adaptation (spacer integration), 
expression (crRNA processing and-maturation and the 
interference stage (target recognition, binding and 
cleavage). The figure is modified from (55). 
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or by an alternative mechanism performed by RNase III, an additional RNA species and 
tracrRNA (transactivating CRISPR RNA) (27)(53)(54).  
The Cas proteins forms the interference Cas complex and binds to the mature crRNA and 
Cas9 or multi-subunit crRNA-effector complex (still bonded, but including Cas3) and this is 
where the interference stage starts (53). The Cas3 gene encodes a large protein with essential 
helicase and DNase activity (57). The interference complex works to prevent expression of 
foreign DNA, like phages, and leads to degradation by cleaving recognition sequences of DNA 
or RNA (53)(54). The spacer sequence can bind foreign DNA by perfect base pairing at the 
PAMs leading to recognition by the interference complex interfering with the foreign DNA 
causing degradation at the R-loop conformation through progressive hybridization (27)(53). 
Many functions and mechanisms are only slightly resolved (27)(53).  
The constant need for evolution of this system has driven a modification of Cas genes 
resulting in multiple CRISPR-Cas systems with different mechanisms (Figure 5) (9). One 
driver that could partly explain the adaptive evolution of the Cas genes is the constant 
competition with virus-encoded dedicated anti-CRISPR proteins (9). Primarily, CRISPR-Cas 
systems are divided into two distinct classes based on the effector module (9)(58). Class 1 
systems performs their functions through multi-subunit effector complexes (9). Whereas, Class 
2 systems functions through single-protein effector modules, making the structure functions 
quite different (9)(58). 
The two classes are also further divided into different subtypes based on phylogeny, function, 
gene arrangement, effector complexes and surrounding genes forming Type I, Type IV and 
Type III for the Class 1 systems and Type II, Type V and Type VI for the Class 2 systems 
(9)(51)(58)(59). See Figure 5.  
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Figure 5: Class 1 and 2 CRISPR-Cas systems and their designated subtypes. Modified from(9). In addition, the 
new subtype I-E* was added displaying the gene arrangement, but not the correct phylogeny and marked effector 
complex because this still needs to be further examined (51). 
Further subtyping (type + uppercase letters) is then done based on functional mechanisms  and 
gene arrangements (9). The overall classifications nomenclature is best illustrated by an 
example from K. pneumoniae harbouring a Class 1 Type I system of subclass E, which is 
referred to a Class 1 Type I-E system (58).  
 
Figure 6: Genetic arrangements including adjacent genetic markers for the Class 1 type I-E and I-E* subtypes 
found in K. pneumoniae (10)(58)(59).   
The I-E and I-E* types are structurally different both in adjacent genetic markers located 
upstream or downstream, Cas gene arrangement and the number of CRISPR arrays, as seen in 
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Figure 6 (10)(58)(59). Signature genes, Cas 1 and Cas 3 both display homology within the 
subtype, but not between the subtypes (11).  
Functional differences is seen as the subtype I-E* can integrate new spacers in both CRISPR 
arrays, however the system in K. pneumoniae seems to favour the second CRISPR array 
(labelled CRISPR3 array in the figure) adjacent to Cas1 (10). This could simply be a result of 
proximity or differences in AT content at the leader sequence for the arrays (10). The CRISPR2 
marked for the I-E* system (Figure 6), has been found to have an AT content from ~46,8% in 
K. pneumoniae and the CRISPR3 an AT content of ~58-75% (10). A study of 40 CRISPR-Cas 
positive K. pneumoniae strains suggested that the I-E* subtype positive had less acquired 
spacers related to phages, plasmids and AMR-genes (including ESBLs), compared to the 
subtype I-E positive strains (11). The subtype I-E* has previously been associated with a lower 
number of plasmids and phage content and a higher susceptibility towards antimicrobial agents 
compared to the subtype I-E (11).  
In addition to the chromosomally bound CRISPR-Cas subsystems I-E and I-E*, K. pneumoniae 
could also acquire ex. subtype IV only found in plasmids (60). The subtype IV has been 
detected exclusively on IncHI1b/IncFIB plasmids and is known to function in cooperation with 
other Cas-genes found in the chromosome (60). However, this system is not fully understood 
and the links to the KpSC must be further examined (60). 
2.2.2 Distribution and genetic conservation 
The CRISPR-Cas system evolved in bacteria as a protective response to invading genetic 
elements and is found with a prevalence of nearly ~50% in bacteria and ~80% archaea 
(9)(11)(20)(51). In total, the Class 1 systems are more prevalent then Class 2 systems and the 
former has been thought to be the ancestor (9). The Class 1 system has mostly been found in 
the chromosome for K. pneumoniae, but plasmid carriage is yet not sufficiently explored (45).  
The Cas-genes display some resemblance, but low degrees of homology is observed between 
system types (58). The classes have already diverged in terms of structure and effector complex 
(58). The individual Cas-genes also display a varying degree of genetic conservation, making 
detection more difficult (58). For the Class 1 type I systems, the Cas1 is the most conserved 
gene with low resemblance to other genetic components (58). However the gene is prone to 
module shuffling and will thus cause difficulties in distinguishing some of the Class 1 systems 
(58)(57). Looking into the phylogeny between the Cas1 in Class 1 type I systems, it is clear that 
some of the subtypes is not easily distinguished (58). This co-evolution of the different types 
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of systems makes bioinformatical subtyping more difficult (58). Since the subtypes typically 
have well conserved PAMs and highly conserved repeats these becomes a good indicator 
alongside one signature Cas gene from the different types and subtypes (58). For the Class1 
type I, Cas3 is the signature gene, despite being a multidomain protein and the close 
resemblance to other genetic components and low degree of conservation (58). However, some 
still argues that Cas1 is the best signature, for all Class 1 systems except type III (57). For the 
subtyping, other adjacent genetic components are required for a higher accuracy (10)(58). This 
is still under investigation.  
2.2.3 Self-targeting spacers and riddance of the CRISPR-Cas system 
A contradiction to the high value of harbouring a functional CRISPR-Cas system is that it often 
contains self-targeting sequences with potential to kill the host (51). The prevalence self-
targeting spacers in CRISPR-Cas positive K. pneumoniae strains (n=18) was found to be 61% 
(51). In their next paper regarding K. pneumoniae, they concluded that out of all the spacers 
(31 of 550) only ~6% were self-targeting sequences towards the host-chromosome or plasmids 
(10). Self-target sequences towards the host prophages were also found (51). In conclusion, it 
could seem like self-targeting spacers in K. pneumoniae harbouring CRISPR-Cas systems 
might not be a rare phenomenon, but these components seems to be tightly regulated/tolerated 
and utilized in scrapping of the system (10). Despite having self-targeting sequences, there is 
no doubt that the main function of CRISPR-Cas system is focused on invading genetic elements 
and host protection (10).  
2.3 Restriction- Modification systems in genetic abundance, 
but less restrictive? 
Since the early 1950s Restriction- Modification (R-M) systems have been recognized as a 
simplistic enzymatic protection mechanism against invading foreign DNA (61)(62). R-M 
systems encode restriction endonucleases that can recognize invading DNA based on their 
restriction sites (RS) and cleaves the DNA in a nucleotide specific way (20)(63). Most of the 
R-M systems recognize dsDNA, while some can recognize ssDNA (63). However, the latter is 
uncommon (63).  
2.3.1 Structure 
The prototype R-M system encodes a restriction endonuclease (REase) and a corresponding 
DNA-methyl-transferase (MTase) (63). The REases recognise un-methylated specific short 
recognition sites (RS), binds to them and hydrolyse the DNA (61)(63). The RS are short and 
well defined palindromic sequenced at 4-8bp, often presented in multiple copies on the target 
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DNA (63)(64). The corresponding MTase is the opponent to the REase, and recognises the 
same sequences in the target DNA and methylate it to protect it from REase degradation 
(61)(63). Thus, the presence of a functional R-M system in a bacteria ensure the methylation 
and protection of the host DNA in contrast to the unprotected, unmethylated invasive DNA 
(63)(64). 
2.3.2 Classification of R-M systems and basic characteristics 
RM systems can be classified based on their origin, functions, subunit composition, 
biochemical properties, cofactor requirements and more (Table 2) (20)(61)(63). Generally the 
systems are divided into four types; type I, II, III and IV with a large variety of subtypes (61). 
The most predominantly seen R-M systems are type I, II and III (20). There are documented 
more than 600 subtypes of the systems, indicating an evolutionary arm race to keep up with 
MGEs (63).  
Table 2: General characteristics of the Type I- IV R-M Systems  
 Subunit 
recognition 











Type I hsdM, hsdS 
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Multifunctiona
l protein (20) 
Yes (61) Translocate 
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The type I, II and III system shares many common factors and some differences (20)(61)(63). 
They are dependent on MTase and REase pairs with matching specificity (20)(61)(63). They 
share the same cleavage and modification sites, but they differ in subunit dependencies and the 
speed they can change specificity and recognise dsDNA (Figure 7) (20)(61)(63).  
The complex formation that occur in example Type I and type III systems forms a 
multifunctional protein consisting of MTase (M), REase (R) and DNA-binding protein (S)(only 
type I) and thus can perform its functions (Figure 7) (63). The type II system is dependent on 
both MTase and REase recognizing the same RS, but they function separately and not in a 
complex (63).  
 
Figure 7: The multifunctional protein complex formation for MTase(M) and REase(R) independent type I, II and III 
RM systems. The S symbolises another DNA-binding protein.  Modified from (63). 
The type IV system contains only a REase, and seems to have evolved to enhance protection 
from phages with modified DNA trying to escape RM systems (63). In this system, the REase 
hydrolyse modified DNA  with a low specificity and with different methylation patterns (63). 
Thus, the type IV system seems to be able to protect the host from a wide range of foreign DNA 
(61).   
Type IIG is defined as a subtype, but it does also share biochemical properties with type III 
systems (61)(63). This type of system is more diverse and consists of a single gene encoding a 
protein with both REase- and MTase activities (63).  
2.3.3 R-M systems- abundance and distribution 
Fragments or complete R-M systems are found in most sequenced bacterial genomes in various 
numbers (65). The average number of R-M systems in prokaryotic genomes has been shown to  
be around 2.6, varying between 0-50 systems per genome in different bacterial phyla, but also 
within species (63). A study of 8500 prokaryotic genomes demonstrated only 385 genomes 
without R-M systems (63)(65).  
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The quantification and distribution of type I-IV R-M systems was also examined in 2261 fully 
sequenced prokaryotic (n=2261) and phage (n=831) genomes by Oliveira et al. (66). The 
authors identified a total of 4743 R-M systems in 2261 genomes and the relative abundance 
was Type II (42%), followed by type I (30%), Type IV (29%) and Type III (8%) (66). 
Moreover, the frequency of R-M systems was dependent upon genome size and the presence 
of MGEs, CRISPR-Cas systems, integrons and the ability to engage in natural transformation 
(66). The number of R-M systems rise with genome size up to 2 Mb, then saturated and declined 
in density (66). Concerning MGE, relative few R-M systems were observed in plasmids, some 
in prophages and very few in phages (66). However, all these MGEs contained incomplete R-
M systems, dominated by solitary MTases (66). Solitary MTases may function as antidotes 
against host R-M systems supporting transfer and stabilization of MGEs in new hosts (66). 
With regard to R-M system types and MGE; the Type III systems were overrepresented in ICEs, 
Type IV underrepresented in all MGEs (consistent with their protective role against invading 
DNA methylation systems), and finally Type IIC were over-represented in all MGEs (66).  
Oliveira et al. also observed significant co-occurrences of Type I- and IV-, Type I- and Type 
III-, and Type IIC- and Type IV R-M systems as well as CRISPR-Cas systems (66). The co-
occurrence of Type I and IV may support the degradation of un-methylated DNA by Type I 
and of methylated DNA recognized by the Type IV system (66). Moreover, they reported a 
significant association between the co-presence of R-M and CRISPR-Cas systems also 
consistent with the very low frequency of spacers (0,01% out of 80685 CRISPR spacers) with 
sequence similarity to R-M systems (66).  
The content of R-M systems varies between strains of the same species indicating rapid R-M 
gene loss and acquisition (63). HGT contributes to the spread and acquisition of R-M systems, 
but the relative contribution of the various transfer mechanisms are not clear (63). The study of 
Oliceira et al. revealed that R-M systems are over-represented in naturally competent 
procaryotes, indication that natural transformation is an important mechanism in HGT of intact 
R-M systems, rather solitary MTases, in plasmids (66). R-M systems can restrain HGT from 
donors, without the same R-M system, especially since longer unmethylated DNA fragments 
are more prone to REase cleavage (63).  
Phage DNA evolves to avoid R-M systems. A natural response from phage DNA is to reduce 
the number of recognition sites to possibly escape the R-M systems (61). However, this 
response is not considered as a universal strategy (61). In addition to RS modification or 
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removal, there are also more specific, but rare, strategies for R-M system avoidance (61). 
Phages have displayed mechanisms like Orc protein (phage T7) inhibiting Type I systems by 
adapting the shape and charge of DNA and hydrolase of the essential ligand S-
adenosylmethionine for Type I and III REases (phage T3) (61).  
Host DNA regulation and degradation. Methylation of genes is an essential part of gene 
expression (63). Studies have shown that methylation contributes to the expression of virulence 
factors and thereby influence bacterial pathogenicity (63). These changes in gene expression 
could various effects, but has been associated with phenotypic switches, for example transition 
to a hypermucoid phenotype (63).  
Genome content and rearrangements are also affected by the localisation of the R-M system 
(63). Because of the selfish nature of R-M systems, they often selectively keep MGEs like 
plasmids containing R-M systems, while cells missing the R-M system is more frequently 
eliminated by REase activity (63). R-M systems have also been shown to contribute differently 
to genome stability (63). Homologous recombination less frequently affects chromosomal 
fragment with R-M systems (63). However, R-M systems might induce recombination when 
making dsDNA breaks (63).  
There are many upsides of harbouring functional R-M systems, but these systems are very 
primitive and could cause problems for the bacteria (61). The system is also mostly effective 
in initial environment adaptation and  phage infection (63). Over time there are other factors, 
like surface receptor modification that will have a larger effect on bacterial ecology (63).  
2.4 Whole genome sequencing in clinical microbiology 
Computational analysis or in silico analysis has since 1990s been a useful way of working with 
DNA sequence data in a larger scale (67). Whole genome sequencing (WGS) is an important 
tool in uncovering the bacterial genome and allowing bioinformatical analyzation to take place 
(68). The method is based on assembling overlapping short reads into longer continuous reads 
(contigs) creating a good coverage of the genome (69). However these methods provides other 
challenges including competence, memory usage, speed, costs and working with sensitive data 
(69). In addition, software updates and critical software assessment is highly needed since new 
information is rapidly uncovered (70).  
WGS and bioinformatic analyses can now be easily utilized in clinical microbiology 
laboratories for rapid detection and characterization (pathogenicity score, AMR and sequence 
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similarities) of clinical relevant bacteria (67)(69). This could have many purposes like choosing 
a beneficial treatment, identifying epidemic strains, outbreaks and tracking spread, all fitted 
into one software (67)(69).  
3 The aim of the study 
Molecular epidemiological studies of various K. pneumoniae strain collections have revealed a 
large genomic diversity associated with HGT (1)(3)(8). Population structure analyses of clinical 
strains have displayed that acquired AMR- and virulence genes are mostly separated in distinct 
subpopulations, MDR- and hypervirulent clones, respectively (1). While MDR clones show a 
large genetic diversity sharpened by HGT, the hypervirulent clones are dominated by a smaller 
subset of genetic lineages (1). To understand the dynamics in genome evolution and diversity, 
one must look at the systems and functions allowing and restricting HGT.  
The CRISPR-Cas and the R-M systems are major participants in the evolution of and 
interactions between MGEs and bacterial hosts. We have a significant knowledge gap in the 
abundance, distribution and diversity of CRISPR-Cas and R-M systems in K. pneumoniae 
populations. Therefore, I have framed a primary aim and several secondary aims for this thesis.  
Primary aim and the research question:  
“Is the presence or absence of CRISPR-Cas- and R-M systems in different K. penumoniae 
populations associated with the presence and absence of MGE represented by acquired 
AMR- and virulence genes or plasmids?”  
The secondary objectives: 
1) Determine the prevalence and subtypes of structurally complete CRISPR-Cas- and R-
M systems in different K. pneumoniae populations  
2) Compare the content of MGEs represented by AMR-, virulence genes and plasmids, in 
K. pneumoniae with and without CRISPR-Cas systems 
3) Compare the content of MGEs represented by AMR-, virulence genes and plasmids, in 
K. pneumoniae with and without R-M systems.  
4 Materials & Methods 
This study is based on bioinformatical analysis of  999 KpSC strains previously characterised 
by WGS and provided through The Norwegian Klebsiella pneumoniae network (NOR-KLEB-
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NET) (http://www.nor-kleb.net/). Bioinformatic methods and programs were chosen based on 
literature and experience in collaboration with my supervisors and researchers within the 
network.  
4.1 Bacterial strain collection 
The strains were obtained from three different sources (Table 3). This research did not involve 
any patient sensitive data.  
Table 3: Strain collection (n=999) and relevant characteristics 








Tromsø 7 study1 484 Carrier isolates Faecal 
NORM 
strains    
(n= 414) 
NORM non-ESBL2 225 Hospital patients Blood 
NORM -ESBL3 189 Hospital and 
community patients 





(NORM (n=34) + 
NORKAB (n=19)) 





48 High risk clone 
Mostly HAI 
Blood, tissue, catheter, 
urine, respiratory, rectal 
++ 
1 Collected from 2015-2016 2 Collected 2001-2015 3 Collected between 2001-2015 4 Collected from January 
2017 to august 2019 5 Collected 2010-2015. ENA-European Nucleotide Archive. NORM: Norwegian 
surveillance system for antibiotic resistance in microbes. NORKAB: Norwegian Klebsiella pneumoniae 
bacteraemia study. 
4.1.1 Carrier strains from the Tromsø7 study 
The faecal carrier strains (n=484) were collected in 2015-2016 from adults ≥40 years old 
participating in the seventh Tromsø (T7) population study (71).  
Briefly, faecal samples were collected using a distributed kit by the participants, transported to 
and processed within the Norwegian National Advisory Unit on Detection of Antimicrobial 
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Resistance (K-res) University Hospital of North Norway (Rafaelsberger N. et al. unpublished 
(72)). The laboratory added 200µl 85% glycerol to the E-swab and stored the samples at -80°C.  
For identification and antimicrobial susceptibility testing (AST) a total of 100 µl was plated 
onto Simmons citrate with inositol agar plates and incubated for 48 hours at 37°C (18)(72). 
Colonies suspected to be Klebsiella were identified using MALDI-TOF MS (72). Colonies 
identified as Klebsiella pneumoniae, Klebsiella quasipneumoniae or Klebsiella variicola was 
selected for further characterization (72). The strains was tested according to EUCAST disc 
diffusion method and breakpoint table, for a total of 12 antimicrobial agents (amoxicillin-
clavulanic acid, piperacillin-tazobactam, cefuroxime, cefoxitin, cefotaxime, ceftazidime, 
aztreonam, mecillinam, gentamicin, meropenem, ciprofloxacin, and trimethoprim-
sufamethoxazole) (72)(73)(74). Whole genome sequencing (WGS) had been performed using 
the MagNA Pure 96 system for DNA extraction, Nextera Flex sample protocol and sequence 
library and sequencing was performed using Illumina MiSeq for 250 or 300bp paired end reads 
at Stavanger University Hospital (Hetland M. et al. unpublished (75)).  
4.1.2 Clinical strains from the NORM study  
The strains from the Norwegian surveillance system for antibiotic resistance in microbes 
(NORM) accounts for a total of 414 strains (76). NORM performs yearly surveillance studies 
by a common study protocol involving all Norwegian microbiology laboratories (76). These 
strains include both non-ESBLs and ESBLs collected mainly from infections in hospital 
patients. However, the collection of strains originating from urine samples (n=67) could be 
from non-hospitalised patients. The strains were selected from NORM studies performed 
during 2001-2015, creating a good diversity (Forstervold A. et al. unpublished (77)). The 
laboratories processed and determined the phenotype of the samples as a part of the normal 
routine by plating out the samples on non-selective agar media, identifying the strains using 
MALDI-TOF and then storing them at -80°C for further analyses. Susceptibility testing was 
performed at the designated laboratories following the EUCAST guidelines (73)(74). Antibiotic 
susceptibility testing was performed using gradient strip test up until 2007 when disk diffusion 
was introduced (77). Isolates with reduced susceptibility towards at least one broad-spectrum 
cephalosporin was systematically tested from 2002 (77). The strains from 2001 with reduced 
susceptibility to either cefpirome or ceftazidime were classified as ESBL producing (77). WGS 
had been performed by Stavanger University Hospital by the same procedure as the carrier 
strains (Hetland M. et al. unpublished (75)).  
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4.1.3 National and international high-risk clone ST307 strains  
The ST307 (n=101) strains were retained from different studies. The Norwegian strains (n=53) 
originated from NORM  (n=34) and the Norwegian Klebsiella pneumoniae bacteraemia study 
(NORKAB) (n=19) (76)(78)(79). The NORKAB study includes blood culture strains from 
nosocomial blood infections in patients over 18 years estimated to cover 90% of the Norwegian 
population (25)(78)(79). Strains were collected during 2017-2019 (25)(79). 
The international ST307 (n=48) was collected from the public European Nucleotide Archive 
(ENA)( https://www.ebi.ac.uk/ena) (80). American strains without all datafiles available where 
excluded. This was because the absence of all file formats enables the original sequence data 
to be available without adjustments/improvements of the actual quality. The other international 
strains had all files, both assembled and the raw data, available providing a higher transparency. 
For these strains, the publicly available information is available in the supplementary table 1. 
The strain material is highly diverse for this collection. 
4.2 Bioinformatic methods and tools 
Multiple tools and programs were utilised in the analysis. Therefore, this section is divided into 
the different categories of interest. The commands used for running each tool, the tool database 
versions and additional scripts used can be found in the Appendix 1. 
4.2.1 Sequencing, assembly and quality control  
Prior to receiving the strains (all strains excluding the ones collected from ENA pre-assembled), 
they were all sequenced, assembled and controlled by the Department of clinical microbiology, 
Stavanger University Hospital.  
Illumina MiSeq sequencing with Nextera Flex kit was performed on all Norwegian strains from 
the Tromsø 7 study, NORM and the NORKAB. The international ST307 was collected using 
enaget, a script for downloading ENA FASTQ files by their accession numbers 
https://github.com/stevenjdunn/enaget. All the strains, including the international ST307 strains 
where quality checked and assembled using the same pipeline; Asmbl available at 
https://github.com/marithetland/Asmbl. Asmbl is a pipeline using multiple programs for fast 
and easy quality control, trimming, assembly and another quality control for the final output. 
Quality parameters set additional to default parameters for Asmbl included GC% match for K. 
pneumoniae, total length match for K. pneumoniae, low number of contigs (ideally <700), 
coverage of 30X and a preference for fewer amounts of long contigs versus a high number of 
short contigs (Hetland M. et al. unpublished). In addition to Asmbl, Prokka version 1.12 
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(available at https://github.com/tseemann/prokka) was utilised for functional annotation of 
contigs >200nt. 
4.2.2 Strain profile: Virulence score, AMR-profile, MLST and plasmid 
content 
Virulence score, AMR-profile, MLST and plasmid content were detected using Kleborate 
version 0.4.0-beta (available at: 
https://github.com/katholt/Kleborate/blob/master/README.md). Kleborate is a complex 
pipeline utilising several databases and programs for the overall profile. Kleborate is specially 
developed for the K. pneumoniae species complex and was run using default parameter 
settings (81).  
Virulence classification roughly categorised the siderophore profile for the strains. The 
virulence score ranged from 0-5 with the following profiles (81): 
Virulence score 0 = none of the acquired virulence loci  
Virulence score 1 = yersiniabactin only 
Virulence score 2 = yersiniabactin and colibactin, or colibactin only 
Virulence score 3 = aerobactin and/or salmochelin only (without yersiniabactin or colibactin) 
Virulence score 4 = aerobactin and/or salmochelin with yersiniabactin (without colibactin) 
Virulence score 5 = yersiniabactin, colibactin and aerobactin and/or salmochelin  
AMR-gene prediction in Kleborate was performed through ARG-Annot database of 
acquired resistance genes with the software SRST2 (81)(69). Short Read Sequence Typing 
for Bacterial Pathogens (SRST2) is especially made for WGS Illumia sequencing data and 
performs searches for resistance genes with a match of 90% as default (69)(82).  
In addition to annotating the resistance genes, according to the affected antibiotic drug class 
and the aggregating the total number of acquired AMR-genes, Kleborate will classify β -
lactamase-encoding genes into six different categories; Bla (β -lactamases), Bla_broad (broad 
spectrum β -lactamases), Bla_broad_inhR (broad spectrum β -lactamases with resistance to β -
lactamase inhibitors), Bla_Carb (carbapenemase), Bla_ESBL (extended spectrum β -
lactamases) and Bla_ESBL_inhR (extended spectrum β -lactamases with resistance to β -
lactamase inhibitors) (81). In order to be able to examine the association between the presence 
/absence of CRISPR-Cas systems and R-M systems and the number of AMR-genes we chose 
 
Page 34 of 109 
a revised classification system. We used the Kleborate system giving us the total number of 
acquired AMR-genes, excluding mutational resistance mechanisms and intrinsic resistance 
genes such blaSHV-, blaOKP-, blaLEN-, fosA- and oqxAB- alleles (1)(3)(28)(29)(48). Other gene 
variations were confirmed by a search at National Center for Biotechnology Information 
(NCBI) (https://www.ncbi.nlm.nih.gov/). Moreover, we classified the strains AMR-gene 
profile in four categories, as shown in Table 4. The revised classification allowed a more 
straightforward analysis of associations between AMR-gene load and the presence or absence 
of CRISPR-Cas- /R-M- systems. 
Table 4: Classification of AMR profiles based on the Giske et al. definition 
Classification Definition Antimicrobial agent classes or genes 
included in the classification 
AMR negative No acquired AMR-genes - 
Non- MDR Acquired AMR-genes to one or two 
classes of antibiotics 
Aminoglycosides (AGly), β -lactams 
(third generation cephalosporins and/or 
carbapenems), Fluoroquinolones (Flq), 
Phenicols (Phe), Rifampin (Rif), 
Sulfonamides (Sul), Tetracyclines (Tet) 
and Trimethoprim (Tmt) 
MDR Acquired AMR-genes to three or 
more classes of antibiotics 
ESBLA, ESBLM and/or 
ESBLCARBA 
Harbours one or more of the AMR-
genes encoding ESBL as defined by 
Giske et al. (24) 
blaCTX-M, blaOXA-, and blaKPC- alleles  
 
MLST examines seven different house-keeping genes and distinguish between different 
genetic strains within a species (83). By using MLST it is possible to identify seven known 
“MLST loci” (rpoB, gapA, mdh, pgi, phoE, infB and tonB) where each unique sequence is 
numbered to distinguish the unique allele numbers in the genome showing a sequence type (ST) 
for the K. pneumoniae species complex (81)(82)(83). The MLST typing is based on the SRST2 
database (69)(82).  
Plasmid detection was performed by Abricate version 0.8 with the PlasmidFinder function for 
plasmid detection using the large PlasmidFinder database to annotate the matching probes  
(https://bitbucket.org/genomicepidemiology/plasmidfinder_db/src/master/). PlasmidFinder 
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database is constructed from WGS collected from NCBI and whole-plasmid sequence data from 
Enterobacteriaceae and therefore well suited (84). The database identifies plasmids based on 
the probe similarity of the replicon sequence (49). In addition, the plasmids are annotated using 
the incompatibility (Inc) groups for Enterobacteriaceae with standardised nomenclature 
(8)(49)(84). Abricate will list the replicon types and summarize the number of sequence 
similarities. The program does not detect if the probes are located on different plasmids or the 
same, and thus the actual number of plasmids could be different than reported by other (49). 
All hits for plasmid replicons were included in the analysis.  
In addition, the plasmid detection was performed without the minimum coverage and minimum 
id by mistake. This resulted in a total of 17% potential false positive nucleotide identity matches 
being accounted as present plasmids. The distribution of the potential false positive matches 
was 9.2% for the carrier-, 7.2% for the NORM- and 0.4% for the ST307 strain collection. 
4.2.3 Phylogeny for ST307 
Phylogenetic analysis was performed using Roary version 3.12.0  available at 
(https://github.com/sanger-pathogens/Roary)(85). Using the annotated GFF3-files from 
Prokka, Roary analysed the pangenome of the low diversity strains producing tree files. 
Unfortunately, five strains were not included in the phylogeny analysis. This was because of 
Prokka skipping annotation of these strains without notifying. This accounts for the strains 
named NORM_BLD_2014_101655, NORM_URN_2015_109059, 
NORM_BLD_2015_115990, NORM_BLD_2015_115991 and NORM_BLD_2015_116357, 
respectively. The accessory binary tree file was visualised using iTol available online at 
https://itol.embl.de/upload.cgi.  
4.2.4 Detection of structural complete CRISPR-Cas system and control 
CRISPR-Cas systems whereas primarily detected using the standalone version of 
CRISPRCasFinder software (available at: https://crisprcas.i2bc.paris-saclay.fr/). In addition, 
some strains were controlled using the online version because of unexpected low evidence level 
ranking from level 1-4, but mostly at level 1 (available at:  -https://crisprcas.i2bc.paris-
saclay.fr/CrisprCasFinder/Index). Level 1 being unlikely systems and level 4 highly promising 
systems based on the mathematical functions (86)(87). The CRISPR-Cas software was run on 
default with the following modifications; the minimum size of direct repeat was adjusted from 
23 to 19 and the minimum spacer size was adjusted from 25 to 20 as advised by Roni Froumine 
and Kelly Wyres working in the KLEB-GAP project. Using the CRISPRCasFinder_Scripts 
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(https://github.com/rfroumine/CRISPRCasFinder_Scripts) all positive strains (evidence level 
1-4)  were summarised in one output file for further assessment. However, the script was 
adjusted to include all evidence levels, not only 3-4 (default) since K. pneumoniae could display 
some difficulties in detection of the systems if the software was to strict.  
Because the software ranked all the strains at evidence level at 1 and the online version at level 
4 for the controlled strains, all strains were assessed using additional software and manual 
assessment using following criteria (86):  
 The Cas-gene array must be complete for the designated system  
 There was one or more CRISPR array with over two spacers 
 The system was detected on the same contig 
The arguments for the given criteria were to assure that the CRISPR-Cas system was a structural 
complete system and thus potentially functional. Since the CRISPRCasFinder software does 
not separate the I-E and I-E* subtypes, manual assessment and additional programs were in 
order (88).  
Since Cas 1 has proven to distinguish between I-E and I-E* systems with conserved homology 
within the subtype, a quick BLAST nucleotide search (version 2.9.0+ available at 
https://anaconda.org/bioconda/blast) against several Cas 1 genes from available K. pneumoniae 
strains from the NCBI database (https://www.ncbi.nlm.nih.gov/genome/) was performed on the 
positive strains from CRISPRCasFinder (Table 5). It could be debated if the Cas 1 is the best 
signature-gene for the typing of subsystem, because Cas 3 is often used as a signature (58)(57). 
However, displays homology to other helicase genes, and can often be wrongly annotated (seen 
in Artemis), Cas 1 was selected for control selection (58)(57). The Cas1 gene amino acid 
sequence from the control strains were manually extracted using Artemis version 18.1.0 
available at https://www.sanger.ac.uk/science/tools/artemis. For Cas 1 detection in Artemis, 
published primers were utilized (10). The extracted sequences were controlled using a 
nucleotide BLAST search at the NCBI database online version with a threshold of 80%, since 
the genes where poorly annotated in Artemis.  
Quick subtyping of the extracted sequences using Cas1, revealed potential controls for further 
synteny examination and a more certain subtyping. The KPNIH27 and NTUH-K2044 (marked 
in bold in figure 5), displayed a good match also for the other primers of the CRISPR-Cas I-E 
 
Page 37 of 109 
and I-E* system. Therefore, they were also used as a control in synteny analysis preformed in 
SimpleSynteny (10)(51).  
Table 5: K. pneumoniae strains from NCBI database were subtyped using Cas1 as a test of PCR primers 
ID Accession number Species System type Cas1_Start Cas1_End 
KPNIH27 CP007731.1 K. pneumoniae I-E 4180320 4181240 
KPNIH31 CP009876.1 K. pneumoniae I-E 4115411 4116331 
CAV1344 CP011624.1 K. pneumoniae I-E 3290664 3291584 
CAV1193 CP013322.1 K. pneumoniae I-E 3310810 3311730 
Kp52.145 FO834906.1 K. pneumoniae I-E 1042853 1043773 
SB3432 FO203501.1 K. pneumoniae 
(rhinoscleromatis) 
I-E 4237324 4238244 
E718 CP003683.1 K. michinganensis I-E 4905442 4906314 
KCTC1686 CP003218.1 K. michinganensis I-E 3414984 3415967 
NTUH-K2044 AP006725.1 K. pneumoniae I-E* 3002916 3003800 
ATCC43816 CP009208.1 K. pneumoniae I-E* 391954 392829 
1084 CP003785.1 K. pneumoniae I-E* 2327874 2328749 
PMK1 CP008929.1 K. pneumoniae I-E* 4767170 4768045 
RYC492 APGM01000001.1 K. pneumoniae I-E* 2106880 2107755 
J1 CP013711.1 K. pneumoniae I-E* 5073325 5074200 
PittNDM01 CP006798.1 K. pneumoniae I-E* 1171218 1172093 
U25 CP012043.1 K. pneumoniae I-E* 3266932 3267807 
KP617 CP012753.1 K. pneumoniae I-E* 564057 564932 
Bold writing mark the selected references for SimpleSynteny 
For the I-E system the NCBI strain KPNIH27 (accession number CP007731.1) full Gene Bank 
file was utilized in Artemis for collecting the nucleotide sequence as a fasta-file for all marker 
genes: Cas1, Cas2, Cas3, Cas5, Cas6, Cas7, CasA, CasB, CysH, iap and Trp (10)(51). The I-
E* reference file was made in the same way using the NTUH_K2044 (accession number 
AP006725.1) isolate with the following reference genes: ABC-Transporter 1, ABC-Transporter 
2, ABC-Transporter 3, Cas1, Cas2, Cas3, Cas5, Cas6, Cas7, CasA, CasB and Glyoxalase 
(10)(51).  
The next criteria were that the systems must have one or more CRISPR array with multiple 
spacers. Because a functioning I-E and I-E* system needs a large array to insert spacers, and if 
its active it should have multiple spacers (9). CRISPRCasFinder did not include a summary the 
number of spacers or CRISPR arrays found and the script did not include it either. The spacers 
could only be found separate in one of the result files (json-file) for each individual strain. All 
the strains were manually controlled using SimpleSynteny, that produced an output including 
a physical space indicating the arrays positions and size. Additional testing and assessment 
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were done, controlling the strains to see how large the CRISPR arrays also had to be to display 
a distance in the SimpleSynteny analysis. On average, the CRSPR arrays was approximately 
the size of the Cas -array to be visual in SimpleSynteny. The spacers were also controlled for a 
random selection in the Jason-files for each strain, where they were listed.  
SimpleSynteny was utilised for investigating the synteny, presence and placements of the 
system components. Also, checking the contigs to see if the systems had been distributed over 
one or several contigs. If they were fragmented, they could potentially be inactive. The software 
is available at: https://www.dveltri.com/simplesynteny/about.html. If the system was placed 
over different contigs, the png-file would display a clear breach and the system could possibly 
be dysfunctional because the location of the components could be anywhere. A functioning 
system relies on close contact of all the components (9). Also, to be able to predict the actual 
synteny of the genes and classify the systems, it is crucial for the systems are located on the 
same contig for higher bioinformatical accuracy.  
Because of software limitations in SimpleSynteny and for the purpose of the png-file with the 
results, the samples were analysed in groups of 20 for the CRISPR-Cas positive strains and 
manually assessed (Appendix 2). Manual assessment ensured that all Cas-genes were present, 
the CRISPR-array was marked by a space, the signature genes upstream and downstream was 
located and that there were no breaches in the contigs. Cut-offs between the adjacent signature 
genes and an otherwise complete CRISPR-Cas system was allowed and counted as positive.  
The program was performed on default settings with a chosen minimum coverage of 80% 
allowing small mutations, as would be expected for the individual systems (58). The minimum 
coverage was chosen based on experimenting with the parameters and seeing when positive 
controls of Cas genes no longer were present. Primarily the Cas 3 revealed a tendency to fall 
out with a minimum coverage >80%. The other Cas genes displayed a much higher similarity 
and only fell out with a much higher minimum coverage.  
4.2.5 Restriction-Modification system detection 
Detection of R-M systems was performed using HMMer profiles available at 
https://github.com/EddyRivasLab/hmmer. The HMMer software mainly is made for mapping 
protein sequences for more advanced detection and production of databases. And therefore, the 
additional scripts provided for easy HMMer profiling were necessary for system detection, 
available at: https://github.com/pedrocas81/RMS?fbclid=IwAR2XonJfGM4UhBYZTQs-
cTXTsA9UUVEVLYaRnJI-bb7aG6Sd8FAO2D9OMp4. The program was performed on 
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default settings. The script running the software did not include any form of instructions or 
examples, the hits-files where concatenated for each dedicated MTase or REase for the different 
types of systems and manually evaluated in Excel and counted. Criterions for systems was that 
they would need to have a matching subtype of MTase and REase for the co-dependent types 
(type I, II and III) and over one REase for the independent Type IV and IIG systems. In addition, 
only one pair of MTase and REase was set as one functional system, even though the system 
could have two MTases of the same subtype as the one REase. This manual assessment results 
in only possible functional systems being accounted as positive. The result files with the manual 
assessments can be found in Supplementary table 4,5 and 6. 
4.3 PCA analysis 
Visualisation of results, making heat plots and doing principal component analysis (PCA) 
analysis was done using R package FactorMineR. PCA plots are often used to explore 
relationships between datasets with multiple factors (89). This applies for both standardised 
data and the PCA plot allows them to be further standardised without losing information (89). 
The data analysed in this study were all categorised into smaller groups summarising the 
information and these data were the base of the PCA analysis (Supplementary table 2) (89).  
The PCA plots are based on the largest difference observed in the Eigenvalues (linear 
representation of the largest to the smallest difference in the dataset) (89). The largest 
eigenvalues are represented on the principal component (PC) axes, making a 2D mapping of 
the results. By adding on concentration ellipses and the average point for the group, the 
definition of the selected groups becomes clearer (89).   
4.4 Statistics  
The Fishers Exact test online calculator was used to investigate if there was any statistical 
significance between the groups (https://www.socscistatistics.com/tests/fisher/default2.aspx). 
A p-value <0,05 was considered statistically significant.  
5 Results  
The result part is organized in six sections. Strain population structure (5.1), Main 
characteristics in the strain collections (5.2), Bioinformatic selection of structural complete 
CRISPR-Cas and R-M systems (5.3), PCA plot comparison of the strains collections (5.4), 
CRISPR-Cas and R-M systems: correlations with virulence profile, AMR classification and 
plasmid content (5.5), and Sub analysis of dominant STs and high-risk STs (5.6).  The raw data 
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are available in Supplementary table 3. The overall results do not include fragmented and 
incomplete CRISPR-Cas- R-M systems, only structurally complete systems according to the 
criteria given in the Material and Methods section.  
5.1 Strain population structure  
The strain collections were grouped in three; carrier- (n=484), NORM- (n=414) and ST307 
(n=101) strains. The NORM strain collection consisted of both ESBL (n=189) and non-ESBL 
(n=225) strains. However, the number of ESBL -producing strains in the NORM -collection 
were different than first assumed. Some strains, harbouring only variants of the intrinsic narrow 
spectrum SHV β -lactamase had simply been misidentified as ESBL-producing (n=45). 
Consequently, several strains were re-classified resulting in only 144 strains classified as 
ESBL- NORM strains. The rest of the strains were classified as the non-ESBL NORM (n=270).  
The carrier strains included a total of 300 different ST types. Only 38 ST types had ≥2 
strains (Figure 8). The most prevalent STs (n≥10) were ST20 (n=15), ST26 (n=13) and ST35 
(n=10) (Figure 8).  
Figure 8:Carrier ST types with ≥2 strains visualised using a treemap. 
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In the NORM collection there was a total of 203 different ST types, where a total of 55 ST 
types had ≥2 strains including ST14 (n=18), ST20 (n=17), ST37 (n=15), ST70 (n=14), ST15 
(n=13) and ST45 (n=13) (Figure 9).  
 
Figure 9: NORM STs with ≥2 strains visualised using a treemap 
 
The ST307 strains are known for being a globally emerging MDR clone. Phylogeny of this 
strain population displayed a relatively similar core genome, but variances in terms of the 
accessory genome (Figure 10). Almost all strains were MDR, ESBL -producing, R-M Type I 
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positive, virulence score 0 and carrying 2-3 plasmids.  
 
Figure 10: Phylogeny of ST307 based on the accessory genome. Made using Roary and iTol 
The distances in the tree display diversity within the strain population. Moreover, some of the 
strains displayed similarities in the selected features marked in the rings which will be 
commented in result section 5.2. Most Norwegian clustered displaying similar features (figure 
10).  
5.2 Main characteristics in the strain populations 
Table 6 summarises the main characteristics in carrier-, NORM (non-ESBL and ESBL) and 
ST307 strains including CRISPR-Cas- and/or R-M systems, virulence score, AMR 
classification and plasmid content. Statistical comparisons between groups, carrier- and NORM 
non-ESBL strains as well as NORM-ESBL- and ST307 strains, are also presented 
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Table 6: Result summary displaying the total number of positive strains and the percentage of the total 
Category Element Carrier 
strains 
n(%) 















144 (30) NS 71 (26) 41(29) 0.00001 0 (0) 
CRISPR-Cas 
negative  
340 (70) 199 (74) 103 (72) 101 (100) 
CRISPR-Cas Class 
1 type I-E 
system* 
92 (19) NS 39 (14) 16 (11) NS 0 (0) 
CRISPR-Cas Class 
1 type I-E* 
system* 










213 (44) NS 115 (43) 38 (26) 0.00001 91 (90) 
R-M system 
negative  
271 (56) 155 (57) 106 (74) 10 (10) 
R-M type I 
system* 
116 (24) NS 51 (19) 28 (20) NS 91 (90) 
R-M type II 
system* 
0 (0) NS 0 (0) 2 (1) NS 0 (0) 
R-M type III 
system* 
19 (4) NS 14 (5) 1 (1) NS 0 (0) 
R-M type IV 
system* 
65 (13) NS 22 (8) 8 (6) 0.00001 0 (0) 
R-M type IIG 
system* 











55 (11) 0.0339 46 (17) 67 (47) 0.00001 6 (6) 
Virulence score 0  429 (89) 224 (83) 77 (54) 95 (94) 
Virulence score 1 48 (10) NS 37 (14) 62 (43) NS 6 (6) 
Virulence score 2 0 (0) NS 2 (1) 0 (0) NS 0 (0) 
Virulence score 3 3 (1) NS 4 (2) 1 (1) NS 0 (0) 
Virulence score 4 0 (0) NS 1 (0) 4 (3) NS 0 (0) 











AMR negative  459 (95) NS 205 (76) 0 (0) NS 1 (1) 
non-MDR 13 (3) 0.0032 21 (8) 11 (8) 0.031 1 (1) 
MDR 12 (2) 0.00001 44 (16)  133 (92) NS 99 (98) 






none plasmids 75 (15) NS 41 (15) 1 (1) NS 2 (2) 
1 plasmid3 71 (15) NS 39 (14) 11 (8) NS 12 (12) 
2-3 plasmids3 212 (44) NS 121 45) 81 (56) 0.0072 74 (73) 
over 4 plasmids3 127 (26) NS 69 (26) 50 (35) 0.0001 13 (13) 
1Fisher exact test displaying the difference between the carrier – and NORM non-ESBL collection. P<0,05 is 
considered statistically significant. 2Statistically difference using Fisher exact test between the NORM ESBL- 
and ST307 strain collections. P<0,05 is considered statistical significance. NS= no statistical difference is (p > 
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0.05). Numbers marked in bold represents the highest percentage distribution(s) within the category. 3Display 
~16% false positives. * Co-occurrence of subsystems are not been taken in consideration.  
In terms of CRISPR-Cas systems, absence of structural complete systems was observed in the 
majority of carrier- (70%), non-ESBL NORM (74%), and ESBL NORM (72%) strains whereas 
a complete absence was observed for the ST307 population. The difference in the prevalence 
of CRISPR-Cas systems between the NORM ESBLs and the ST307 was statistically 
significant. Both Class I-E and I-E* were detected and co-occurred in 7 strains.  The occurrence 
of structural complete R-M systems varied between the groups; the carrier (44%), non-ESBL 
NORM (43%), ESBL-NORM (26%) and ST307 (90%). R-M Type I was the dominant system. 
Co-occurrent R-M systems were observed and will be commented below. Between the ST307 
and the NORM ESBLs there was a statistically significant difference in the prevalence of R-M 
negative and positive strains. For all the strain populations, virulence score 0 (no acquired 
virulence loci) were the most prevalent. A significant higher positive virulence score was 
observed in non-ESBL NORM strains compared to carrier strains. Likewise, a significant 
higher virulence score was observed in ESBL-NORM strains compared to ST307 strains. As 
expected, the carrier and NORM non- ESBL groups had the highest prevalence of AMR 
negative strains with no statistical significant difference between them (p = 0.06). NORM 
ESBL and ST307 had the highest prevalence of MDR and ESBL -producing strains, with no 
statistical significant difference between the groups. The plasmid content was similar between 
groups between carrier and non-ESBL NORM strains with a relative high proportion of strains 
(15%) with no plasmids compared to the ESBL-NORM and ST307 strains. There was a 
statistical significant difference between the ESBL-NORM and ST307 strains concerning the 
proportion of strains within the 2-3 plasmid and ≥ 4 plasmids categories. 
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Figure 11 present the main 
findings in a heatmap format. 
Overall, the strains displayed 
many features in common. 
However, the data also displayed 
small differences within 
distribution of e.g. the different 
R-M Types. ST307 strains 
displayed a more uniform overall 
profile with smaller differences 
within each category. The 
NORM ESBL strains displayed a 
different tendency by having the 
largest percentage of R-M system 
negative strains and also carrying 





5.3 Bioinformatic selection of structural complete systems 
Only structural complete and therefore potentially functional CRISPR-Cas- and R-M systems 
were included in the results. Methodical assessment of the systems using multiple programs 
were necessary to not only subtype the systems, but also to detect fragmented- and incomplete 
systems. Multiple deleted or lack of Cas-genes or non-matching MTase/REase were observed.  
Using the strict criteria for CRISPR-Cas detection, a total of 24 CRISPR-Cas Class 1 Type I-E 
systems detected in CRIPSRCasFinder for the carrier strains was assessed as negative using 
BLASTn and SimpleSynteny (Figure 12). This was due to the lack of several Cas-genes, 
breaches in contigs or lack of Cas1. CRISPR-Cas Class 1 Type I-E* system in the carrier strains 
displayed either a complete presence or severe fragmentation. For the NORM strains, a total of 
Figure 11: Percentage distribution of the selected features (CRISPR-
Cas systems, R-M systems, virulence-, AMR profile and plasmid 
classification). This heatmap was made in R-studio using FactorMineR. 
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22 CRISPR-Cas Class 1 Type I-E and 2 I-E* systems were, for the same reasons, assessed 
negative. The ST307 did not harbour any complete or fragments of CRISPR-Cas systems. 
  
 
Figure 12: Results from SimpleSynteny analysis for both CRISPR-Cas Class 1 I-E and I-E* systems for a 
selection of 20 strains. The green plus signs display structurally complete systems, the red x indicate one 
incomplete I-E system and the ones without any symbols are clearly incomplete I-E and I-E*l systems.   
The png-file from SimpleSynteny comparing the same strains for both CRISPR-Cas Class 1 
Type I-E and I-E* displayed mostly clear boundaries between the presence or absence of 
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complete systems (Figure 12). The systems were classified and manual assessment ensured that 
all Cas-genes were present (labelled arrows), the CRISPR-array was marked by a significant 
space (beige with stripes), the signature genes upstream and downstream was located (labelled 
arrows) and that there were no breaches in the contigs (clear cut-offs in white). Cut-offs 
between the adjacent signature genes and otherwise complete CRISPR-Cas system was allowed 
(see T7-048 reference I-E in Figure 12).  
To ensure that the R-M systems were structural complete according to the criteria given in the 
methods section, all systems were assessed to ensure that the strain had MTases and REases 
within the same type of R-M system and the same subfamily (valid for type I, II and III 
systems)(Figure 13). The other systems (IV and IIG) only needed a match for REase. The total 
prevalence of R-M systems was much lower than expected and potentially because of manual 
selection of only complete systems. 
 
Figure 13: Concatenation of one example strain from R-M Type II systems displaying a total of 5 MTases and one 
REase that does not match any of the MTases. This indicates fragments of R-M systems being present. 
The prevalence and actual positive R-M systems (matches) found in the systems are displayed 
in Table 7. Overall there were more MTases, than REases in all the systems with co-
dependence.  
Table 7: Number of MTases and REases found in validation of complete R-M systems in all strain populations.  
Strain 
population 




MTase REase Match MTase REase Match MTase REase Match REase REase 
Carrier 
strains 
373 321 116 2138 75 0 24 23 19 65 51 
NORM 
strains 
280 217 51 1442 69 0 22 20 14 49 30 
ST307 
strains 
206 107 91 471 97 0 0 0 0 0 1 
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In total, if the R-M systems MTasse/REase subtypes had not been evaluated, the carrier strains 
would display a total of ~1.1 R-M systems per strain. With a proper manual evaluation, the 
average was found to be ~0.6 R-M systems per strain. Correspondingly the NORM strain 
collection would display a total of ~0.9 R-M systems per strain but were assessed to be ~0.4 R-
M systems per strain. Likewise, ST307 displayed ~0.9 R-M systems per strain before evaluation 
and ~0-4 R-M systems per strain after evaluation.  
5.4 PCA plot comparison of the strain collections 
A PCA plot illustrates the grouping of the strain populations (carrier-, NORM non-ESBL-, 
NORM ESBL and ST307 strains), based on their selected features (Figure 14). 
 
Figure 14: PCA plot displaying the distribution of the selected features (CRISPR-Cas, R-M systems, virulence 
score, AMR classification and plasmid content) grouped by the strain populations; Carrier- (n=484), NORM non-
ESBL- (n=270), NORM ESBL- (n=144) an ST307 (n=101) strains. The ellipses display the concentration of the 
group and the average points (highlighted by added black symbols), display the average point for the group. This 
PCA scatter plot was generated using R studio and FactorMineR.  
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The largest difference seen by the separating concentration ellipses for the strain collections 
seemed to be affected by the presence or absence of ESBL alleles, in which they were classified 
by in the first place. However, the total eigenvalues in PC1 only displayed a total of 14,3% 
difference. The carrier strains and NORM non-ESBL strain population had the most in common 
with overlapping ellipses. Next, NORM ESBL and ST307 had many features separating them 
from the carrier and NORM non-ESBL population. The overlap between ST307 and NORM 
ESBL strains was almost complete.  
The average point (the oversized black points) of the carrier- and NORM non-ESBL strains 
were placed a little apart both in the PC1 and PC2 axis, displaying differences in the 
eigenvalues. NORM ESBL- and the ST307 strains had a more defined separation between the 
average points in PC2, but a higher similarity in PC1. Interestingly, the distance between 
NORM ESBL and the ESBL negative strains (Carrier and NORM non-ESBL) in PC2 were 
quite small, compared to the ST307.  
5.5 CRISPR-Cas and R-M systems and their correlation with 
virulence profile, AMR classification and plasmid content 
The correlation between different combinations of presence-absence of CRISPR-Cas and/or 
R-M systems and their correlation to virulence profile, AMR -classification and plasmid 
content is given in this section. 
5.5.1 CRISPR-Cas positive and negative strains: population 
comparisons, virulence score, AMR classification and plasmid 
content 
Looking closer into the distribution of CRISPR-Cas systems in the strain populations revealed 
significant differences between ST307 and the other populations (Figure 15). ST307 displayed 
a complete CRISPR-Cas negative profile in contrast to the NORM ESBL population (Table 6). 
Moreover, no components or fragments of CRISPR-Cas components were detected in the 
ST307 strains. The other strain populations had a more similar CRISPR-Cas distribution and 
did not display any statistically significant difference between the presence/absence or system 
distribution between the carrier- and NORM non-ESBL strains (Table 6).  
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Figure 15: Prevalence and percentage distribution of CRISPR-Cas systems (n=256) in all strain populations.  
A total of 26% (n=256) of the strains were defined as CRISPR-Cas positive (Figure 15). A total 
of 14% (n=140) were Class 1 Type I-E strains, 11% (n=109) Class 1 Type I-E* strains and 
0,7% (n=7) harboured both subtypes. The MLST types associated with this co-occurrence was 
ST129 (n=2), ST790 (n=1), ST427 (n=1), ST1613 (n=1), ST1119 (n=1) and ST4290 (n=1). The 
distribution of subtypes was found to be a total of 59% for the I-E type and 41% I-E* amongst 
the CRISPR-Cas positive strains.  
Further analysis of differences between the CRISPR-Cas presence/absence strains visualised in 
a PCA plot, revealed small differences between the groups (Figure 16). The PCA plot grouped 
all the strains based on their CRIPSR-Cas profile (absence, only subtype I-E, both subsystems 
and only subtype I-E*) separating them by their selected features. The presence/absence of R-
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Figure 16: PCA plot displaying the distribution of the selected features (R-M systems, virulence score, AMR 
classification and plasmid content) grouped by the absence of CRISPR-Cas systems (n=743), CRISPR-Cas Class 
1 Type I-E systems (n=140), CRISPR-Cas Class 1 Type I-E and I-E* systems (n=7) or CRISPR-Cas Class 1 Type 
I-E* system (n=109). The ellipses display the concentration of the groups and the average points (highlighted by 
added black symbols), display the average point of the groups. This PCA scatter plot was generated using R studio 
and FactorMineR. 
The concentration ellipses in Figure 16 indicated a complex relationship between the absence 
and the presence of the different CRISPR-Cas subsystems in all strain populations. All the 
points for the specific strains were scattered across the plot with much overlap. Absence of 
CRIPSR-Cas in the strain populations had a large overlap with presence of CRISPR-Cas 
systems. Moreover, CRISPR-Cas Class 1 Type I-E* displayed only small differences compared 
to the strains with absence of the systems. CRISPR-Cas Class 1 Type I-E had an overall more 
concentrated ellipse with an almost complete overlap of the absent group. Strains harbouring 
both types of CRISPR-Cas subsystems (I-E and I-E*), seemed to be more defined in PC1 and 
had the largest difference compared to the strains with no CRISPR-Cas systems. Looking at the 
ellipse concentration points, the largest difference on PC1 was between strains harbouring both 
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Type I-E and I-E* versus only type I-E*. In the PC2 axis it can be debated witch of the absent 
and Type I-E* concentration points are located furthest away.  
Further we investigated closer the actual features separating these groups. PCA analysis 
differentiating between CRISPR-Cas Class 1 System Type I-E or I-E*, compared to both 
systems, displayed differences between all populations across both axis (Figure 17).  
 
Figure 17: PCA plot displaying the distribution of the selected features (R-M systems, virulence score, AMR 
classification and plasmid content) sorted by their CRISPR-Cas Class 1 Type I-E (n=140), CRISPR-Cas Class 1 
Type I-E and I-E* (n=7) and CRISPR-Cas Class 1 Type I-E* systems (n=109). The ellipses display the concentration 
of the groups and the average points (highlighted by added black symbols), indicates the average point for the 
group. This PCA scatter plot was generated using R studio and FactorMineR. 
Compared to each other, the subtype I-E and I-E* displayed a different distribution compared 
to the previous PCA pot (Figure 17). In the total comparison, the Type I-E* were more defined 
and smaller than the distribution of Type I-E. This plot indicated differences between the 
CRISPR-Cas systems in both PC1 and PC2. Type I-E strains displayed the largest difference 
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to strains harbouring both systems and the Type I-E* strains were found in the middle of both 
groups. However, the biggest difference comprised a total of maximum 16,8% difference.   
Analyses of the selected features (virulence profile, AMR classification and plasmid content) 
within the categories of strains used in the previous PCA plot, displayed small differences 
between the groups (Figure 18). The CRISPR-Cas I-E and I-E* category is included in the 
comparison although the number of strains (n=7) is very low. 
 
 
Figure 18:The percentage distribution of the selected features (virulence profile, AMR classification and plasmid 
content), grouped by the absence of CRISPR-Cas systems (n=743) or the presence of CRISPR-Cas Class 1 Type 
I-E (n=140), presence of both CRISPR-Cas Class 1 Type I-E and I-E* systems (n=7) and presence of CRISPR-
Cas Class 1 Type I-E* systems (n=109).   
The virulence profiles only differed by small percentages for all the categories, except 
CRISPR-Cas Class1 Type I-E* (n=109) displaying a total of 33% strains harbouring acquired 
virulence factors (virulence score 1-5) compared to 14-19% for the other groups. The presence 
of virulence factors was not significant between the Type I-E and I-E* systems (p=0.2128).  
The AMR classification displayed the highest prevalence of AMR negative strains in CRISPR-
Cas Class1 Type I-E and I-E* positive strains (n=7), by 100%. Next, were the CRISPR-Cas 
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Class 1 type I-E strains (n=140) with 70% AMR-negative and last, the strains with absence of 
CRISPR-Cas systems with 51% and CRISPR-Cas Class 1 Type I-E* strains with 51% AMR-
negative strains. The number of AMR negative strains displayed a statistical significant 
difference between the Type I-E systems and strains harbouring both systems (p=0.00001). Non 
-MDR strains were found in a total of 3% for CRISPR-Cas negative strains, 7% for both the 
CRISPR-Cas Class 1 Type I-E strains and the CRISPR-Cas Class 1 Type I-E* systems. MDR 
strains were found in the highest percentage of 25% in the CRISPR-Cas negative strains, 13% 
in CRISPR-Cas Class 1 Type I-E strains and 24% in CRISPR-Cas Class 1 Type I-E * strains. 
The MDR content was significant different between the strains with absence of CRISPR-Cas 
systems and the strains with Type I-E* (p=0.00001). ESBL -production had the largest presence 
in the strain population without CRISPR-Cas (21%). This group included all ST307 strains 
(n=101). The second highest ESBL -production were found in 19% of the strains with CRISPR-
Cas Class 1 Type I-E* systems and lastly, 10% amongst CRISPR-Cas Class 1 Type I-E strains. 
Overall, in decreasing order, the CRISPR-Cas positive strains harbouring both of the Class 1 
Type I-E and I-E* subtype had the lowest AMR profile, CRISPR-Cas Class 1 Type I-E the 
second lowest, third lowest (based on prevalence of MDR and ESBL -producing strains) is the 
systems without CRISPR-Cas systems and last, the strains with CRISPR-Cas Class 1 Type I-
E.  
The plasmid profiles displayed similar proportions of absence of plasmids in the various strain 
categories. The categories of 2-3 plasmids  and ≥4 plasmids were the highest in the CRISPR-
Cas negative strains by 77%, Second highest in the CRIPSR-Cas Class 1Type I-E strains by 
72%, thirdly a 67% carriage in the CRISPR-Cas Class 1 Type I-E* strains and lastly, 43% 
carriage in the CRISPR-Cas Class 1 Type I-E and I-E* strains.  
5.5.2 R-M system positive and negative strains: population 
comparisons, virulence score, AMR classification and plasmid 
content 
The distribution of R-M systems in the strain collections is presented in Figure 19. Briefly, 
contrary to the complete absence of CRISPR-Cas systems for the ST307 strain collection, a 
total of 90% were R-M Type I positive. The NORM ESBL population displayed a total of 26% 
R-M system positive strains which is lower compared to the NORM non-ESBL (57%) and 
carrier (50%) strains populations. A total of 19% R-M systems was classified Type I, 1% Type 
II, another 1% Type III, 6% Type IV and lastly 3% Type IIG. Statistically significant 
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differences between the R-M systems presence/absence and distribution of R-M Type IV and 
IIG systems between ST307 and NORM ESBL were observed (Table 6).  
There was no statistical difference between the presence/absence of R-M systems between the 
NORM non-ESBL and the carrier strain collection (Table 6).  
 
Looking at the overall strain collections, a total of 51% (n=511) of the strains were R-M system 
negative and 49% (n=488) were R-M system positive. The most prevalent R-M Type I occurred 
in a total of 29% (n=286) of the total strain populations. The Type II was present in two strains, 
Type III 3% (n=34), Type IV 10% (n=95) and Type IIG 10% (101).  
In addition to simply looking at the presence or absence of the R-M systems, a total of 35 strains 
had two occurrences of R-M Type I, two of them in co-occurrence with R-M Type IV and one 
in co-occurrence with R-M Type IIG. Additionally, one of the ST307 strains had three R-M 
Type I systems.  
Co-occurrences of different R-M system types were found in a total of 60 strains. Their origins 
were from all the strain populations, carrier (n=38), NORM non-ESBL (n=15), NORM ESBL 





























Prevalence and distribution of R-M systems in all 
strain populations*
R-M type I (n=286) R-M type II (n=2) R-M type III (n=34)
R-M Type IV (n=95) R-M type IIG (n=101) R-M negative (n=511)
Figure 19: Prevalence and percentage distribution of R-M systems (n=488) in all strain 
populations. *Including co-occurrence of R-M systems (n=60). 
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Figure 20: Number of strains found in ten different co-occurrences of R-M systems in a total of sixty strains.  
The co-occurrence was seen in a total of 10 different combinations of both double and triple 
combinations (Figure 20). The most prevalent co-occurrence was the Type I and IV.  
For the R-M systems, a PCA plots grouped the strains by the presence versus absence of R-M 
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Figure 21: PCA plot displaying the distribution of the selected features (CRISPR-Cas, virulence profile, AMR- 
classification and plasmid content) sorted by the presence (n=457) or absence of R-M systems (n=542). The 
concentration ellipses display the average distribution of the groups and the average points (highlighted by added 
black symbols) display the group average point. This PCA scatter plot was generated using R studio and 
FactorMineR. 
The overall spread PCA plot indicated only small differences between the presence/absence of 
R-M systems. The ellipses were mostly overlapping with only small differences separating the 
populations across the PCs. The individual points were mostly located in the same areas. The 
average points for the populations were close together and only revealing small differences 
between the groups.  
PCA analysis of the total distribution displaying all single and multiple co-occurring R-M 
systems, were too complex and did not show a good distribution. Therefore, they were all 
categorised as single and multiple systems (Figure 22).  
 
Page 58 of 109 
 
Figure 22: PCA plot displaying the distribution of the selected features (CRISPR-Cas, virulence score, AMR 
classification and plasmid content) sorted by the absence (n=541) or presence of single R-M systems (n=398) or 
multiple R-M systems co-occurring in the same strain (n=60). The ellipses display the concentration average of 
the groups and the average points (highlighted by added black symbols) display the group average point. This 
PCA scatter plot was generated using R studio and FactorMineR. 
The difference between the previous presence/absence plot (Figure 21) and Figure 19, is mainly 
the location of the concentration ellipse of the strains with co-occurrence of multiple systems. 
The group of multiple systems displayed similarities with both groups, however it shared the 
most features with the group not harbouring any R-M systems. The concentration ellipses 
mainly overlapped, and the individual points were scattered in the same areas. In total, the 
largest difference indicated only ~19% difference in the features (PC1). However, the average 
points were slightly separated by the absence in the middle. Moreover, the total concentration 
ellipses displayed small variances between the populations. 
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Analysing their profiles (virulence score, AMR -classification and plasmid content), based on 
the occurrence of single systems, multiple systems or the absence of R-M systems, indicated 
small variances (Figure 23). 
 
Figure 23: Percentage distribution of the selected features (virulence score, AMR classification and plasmid content) 
based on the absence of R-M systems (n=541), presence of single R-M systems (n=398) or presence of multiple 
R-M systems co-occurring in the same strains (n=60).  
The virulence profiles for the different R-M categories was quite similar (Figure 23). In total, 
the strains with multiple R-M systems in co-occurrence displayed 88% of the strains without 
any acquired virulence factors (virulence score 0), 84% of the single R-M systems were 
virulence negative and last, the 81% of strains without any R-M systems without acquired 
virulence factors. There was a significant difference in virulence negative strains between the 
group without R-M systems and the group with single R-M systems (p=0.00001).  
AMR profiles for the strains displayed a more complex relationship between the groups (Figure 
23). The proportion of AMR negative strains were highest in the multiple R-M systems (72%), 
followed by strains without R-M systems (58%) and single R-M system strains (46%).  
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The prevalence of AMR negative strains was significant different for the strains with no R-M 
system compared to the ones with single R-M systems (p=0.00001). Overall, the strains with 
multiple systems, displayed a lower content of resistance genes. The R-M negative strains 
displayed the second highest prevalence of resistance genes. Lastly, the strains with single R-
M systems had the highest percentage of resistance, especially MDR and ESBL.  
In terms of plasmids, 13% of the R-M negative group, 10% of the single R-M systems and 
8% of the group with multiple systems had no plasmids. The plasmid load ≥4 plasmids were 
significant different between the R-M negative group and multiple R-M group (p=0.00001). 
 Both the single and multiple R-M systems displayed the same plasmid content higher than for 
the R-M negative strains. Overall the R-M negative group seemed to display the least number 
of plasmids increasing for the number of R-M systems.  
5.6  Co-occurrence of CRISPR-Cas- and R-M systems: 
population comparisons, virulence score, AMR 
classification and plasmid content 
Figure 24 displays the PCA plot grouped by absent (neither CRISPR-Cas- or R-M system), 
only CRIPSR-Cas systems, only R-M systems or both CRISPR-Cas and R-M systems.  
In total, the group carrying both CRISPR-Cas and R-M systems consisted of 71 carrier strains 
and 45 NORM strains (non-ESBL (n=33) and ESBL (n=12)). Only R-M (n=342) was seen for 
143 carrier strains, 108 NORM strains (non-ESBL (n=82) and ESBL (n=26)) and 91 ST307. 
The group only containing CRISPR-Cas systems (n=140) consisted of 73 carrier strains and 
67 NORM strains (non-ESBL (n=38) and ESBL (n=29). The group that did not contain any 
systems (n=401) was comprised of a total 197 carrier strains, 194 NORM strains (non-ESBL 
(n=117) and ESBL (n=77)) and ST307 (n=10) strains. ST307 was only represented in the 
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group harbouring R-M systems and no other systems. 
 
Figure 24: PCA plot displaying the distribution of the selected features (virulence score, AMR classification and 
plasmid content) sorted by the presence of only CRISPR-Cas systems (n=140), only R-M systems (n=342), both 
CRISPR-Cas- and R-M systems (n=116) and absence of both systems (n=401). Including their designated 
concentration ellipses and average points (highlighted by added black symbols), displaying the average point of 
the group. This PCA scatter plot was generated using R studio and FactorMineR 
By looking at the concentration ellipses, there were small differences in the features between 
the groups. The maximum percentage difference was 22,6%. All groups had overlaps, but it 
seemed as the largest similarity was between strains harbouring only CRISPR-Cas systems and 
those with both systems. Secondary, the groups without any system also showed resemblance 
with the strains not harbouring any systems. This was seen for both the concentration ellipses 
and the average concentration points. The group with the largest difference was the ones only 
harbouring R-M systems. They revealed the largest difference at PC2.   
Closer analysis of the selected features (virulence score, AMR classification and plasmid 
content) grouped by the presence of only CRISPR-Cas-, only R-M-, negative for all systems 
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and both CRISPR-Cas- and R-M systems, displayed small variances between the systems 
(Figure 25).  
 
Figure 25: Percentage distribution of the selected features (virulence score, AMR classification and plasmid content) 
for all the strain collections grouped by the presence of only CRISPR-Cas systems (n=140), only presence of R-M 
systems (n=342), both CRISPR-Cas- and R-M systems (n=116) and the strains without CRISPR-Cas- and R-M 
systems (n=401).  
An overall low virulence score was observed within each group. Virulence score 0 was lowest 
in the CRISPR-Cas system only group (71%) compared to the R-M system only group (86%), 
CRISPR-CAS and R-M system group (81%), and the CRISPR-Cas and R-M negative group 
(84%). The proportion of virulence positive strains with only CRISPR-Cas were significantly 
different from the virulence positive strains with both systems (p=0.0118). In addition, there 
was a significance with virulence score 0 between harbouring only CRISPR-Cas systems and 
no systems (p=0.00001). 
Resistance profiles displayed some variations between the groups. The highest proportion of 
AMR negative strains was observed in the CRISPR-Cas and R-M group (69%) compared to 
the CRISPR-Cas and R-M negative group (58%), the CRISPR-Cas only group (57%), and the 
R-M only group (43%). There was no significant difference in the proportion of AMR negative 
strains between the group with only CRISPR-Cas systems and the group with both systems 
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(p=0.5783). There was however a significant difference in AMR negative strains between both 
systems and the group with no system (p=0.00001). In total, the group with only R-M systems 
had the highest number of resistance genes, followed by the group without systems and the 
similar group with only CRISR-Cas systems, leaving the group of both systems with the lowest 
percentage of resistance mechanisms.  
The plasmid profile in the CRISPR-Cas only group showed that a total of 10% were without 
plasmids, which was similar to the R-M only group (10%), the CRISPR-Cas and R-M group 
(11%) and higher in the CRISPR-Cas and R-M negative group (15%).  The proportion of strains 
with ≥ 2 plasmid was approximately the same within each group: CRISPR-Cas only group 
(68%), R-M only group (79%),  the CRISPR-Cas and R-M group (71%), and the CRISPR-Cas 
and R-M negative group (74%). There was a significant difference in carrying ≥2 plasmids 
between the group with only R-M systems and the group with only CRISPR-Cas systems 
(p=0.00001). There was a significant difference in harbouring ≥4 plasmids between the group 
with only R-M systems and the group with no systems (p=0.0018). There was a significant 
difference carrying ≥4 plasmids between the group with both systems and the strains with only 
R-M systems (p=0.0027). There was not a significance in harbouring ≥4 plasmids between the 
group with both systems and the group with only CRISPR-Cas systems (p=0.5434). 
5.6.1 Plasmid content in relation to CRISPR-Cas- and R-M systems 
Moving into analysing the plasmid content of all the strains, they all had similarities between 
the strain populations (Figure 26). Lack of threshold in the bioinformatic plasmid detection, 
resulted in a total of 17% false positive nucleotide matches. These strains are marked with red 
in the Supplementary Table 2.  
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On average of 2.3 plasmids per carrier 
strain, 2.7 plasmids per NORM strain 
and 2.5 plasmids per ST307 strain were 
observed. In all strain populations the 
maximum number of plasmids was 
seven. 
The most frequently found plasmid 
replicons were the ColRNAI_1 (n=250), 
INFIB(K)_1_Kpn3 (n=725), 
IncFII_1_pKp91 (n=548), 
IncFIA(HI1)_1_HI1 (n=135),  
IncFIB(Mar)-1_pNDM-Mar (n=41), 
IncFIB(pKPHS1)_1_pKPHS1 (n=76),  
and IncN_1 (n=60) and IncR_1 (n=130). 
In addition to these groups, some were 
seen more exclusively for certain groups. 
For example, the Col(MGD2)_1 (n=35) 
had a higher presence in the carrier and 
the NORM non-ESBL strain collection, 
decreasing or absent in the NORM-
ESBL and ST307 population. The 
IncFiB(pQil)-1_pQil (n=24) was predominantly 
seen in the NORM ESBL strains and in the ST307 population.  
5.6.1.1 Plasmid distribution in the strain populations 
Looking into the total of plasmids sorted into the selected groups, displayed similarities 
between the carrier- and the NORM non-ESBL strains, but a higher prevalence and different 
profile in the NORM ESBL- and ST307 strains (Figure 27).  
Figure 26: Percentage distribution of the total plasmid 
profile for all the strain populations. This heatmap was 
made using R -studio FactorMineR. Note that ~17% might  
display false positives.  
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Figure 27: Percentage distribution of the plasmid categories within the different strain populations.  
The total plasmid content for the carrier- and the NORM non-ESBL strains was only 
differing by 1%. The proportions of strains in the carrier (15%) and the NORM non-ESBL 
(15%) were significantly lower than in the NORM-ESBL (1%) and the ST307 (2%) 
populations. Correspondingly, the proportions of strains with a plasmid load ≥ 2 were 
significantly higher in the NORM-ESBL (91%) and ST307 (86%) populations compared to 
the carrier (70%) and NORM-non-ESBL (71%) populations.  
To better understand the effects of CRISPR-Cas- and R-M systems effects on plasmid content 
in the different strain populations, one must look at the individual strain populations. Starting 
by the carrier strains (Figure 28). The total of the strain population is summarised in the black 
frame and the rest is classified by the presence and/or absence of CRISPR-Cas- and R-M 
systems. 
 
Figure 28: Percentage distribution of the plasmid categorisation for the carrier strain population (n=484), based on 
the total strain population (marked by frame), presence of only CRISPR-Cas systems (n=73), only R-M systems 
(n=143), both CRISPR-Cas- and R-M systems (n=71) and the strains without CRISPR-Cas- and R-M systems 
(n=197).  
The proportion of carrier strains with no plasmids varied between groups: CRISPR-Cas only 
(8%), R-M only (14%), CRISPR-Cas and R-M (14%), and finally CRISPR-Cas and R-M 
negative group (20%). There was a significant difference in no plasmids between the group 
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with only CRISPR-Cas systems and the group with only R-M systems (p=0.0044). There was 
no significant difference in no plasmids between only CRISPR-Cas systems and the group 
with both systems (p=0.4284). The proportion of strains with a plasmid content ≥ 2 was 
highest in the R-M only group (77%), followed by the CRISPR-Cas and R-M negative group 
(69%), the CRISPR-Cas and R-M positive group (68%), and the CRISPR-Cas only group 
(59%).  In total, the lowest plasmid load was found in the strains with only CRISPR-Cas 
systems, judging by the total percentage of the classes over two plasmids. There was a 
significant difference between the plasmid content ≥4 between the group with only CRISPR-
Cas- and the group with only R-M systems (p=0.0483).  
For the NORM non-ESBL strain population, a total of 38 strains had only CRISPR-Cas 
systems, 82 with only R-M systems, 33 with both CRISPR-Cas- and R-M systems and 117 
without any of these systems (Figure 29).  
 
Figure 29: Percentage distribution of the plasmid categorisation for the NORM non- ESBL strain population 
(n=270), based on the total strain population (marked by the frame), presence of only CRISPR-Cas systems 
(n=38), only R-M systems (n=82), both CRISPR-Cas- and R-M systems (n=33) and the strains without CRISPR-
Cas- and R-M systems (n=117). 
The proportion of NORM non-ESBL strains with no plasmids varied between groups: 
CRISPR-Cas only (18%), R-M only (15%), CRISPR-Cas and R-M (9%), and finally 
CRISPR-Cas and R-M negative group (16%).  The proportion of strains with a plasmid 
content ≥ 2 was highest in the CRISPR-Cas only group (74%), followed by CRISPR-Cas and 
R-M negative group (71%), the R-M only group (70%), and the CRISPR-Cas and R-M 
positive group (66%). The observed differences were not considered significant.   
The NORM ESBLs displayed a total of 29 strains with Only CRISPR-Cas systems, 26 with 
only R-M systems, 12 with both CRISPR-Cas- and R-M systems and 77 without any systems 
(Figure 30). 
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Figure 30: Percentage distribution of the plasmid categorisation for the NORM ESBL strain population (n=144), 
based on the total population (marked by the frame), the presence of only CRISPR-Cas systems (n=29), only R-
M systems (n=26), both CRISPR-Cas- and R-M systems (n=12) and the strains without CRISPR-Cas- and R-M 
systems (n=77). 
Almost all NORM-ESBL strains contained plasmids. The proportion of strains with a plasmid 
content ≥ 2 was highest in the CRISPR-Cas and R-M positive group (100%), followed by the 
R-M only group (96%), the CRISPR-Cas and R-M negative group (92%), and the CRISPR-
Cas only group (82%). The difference in ≥4 plasmids was significant between the group with 
no systems and both systems (p=0000.1). Moreover, there was a significant difference in ≥4 
plasmids for the only CRISPR-Cas group compared to the only R-M group (p=0.0279).  
The ST307 strain population was the only group without CRISPR-Cas systems, and therefore 
the groups were divided into only R-M systems (n=91) and the ones without R-M systems 
(n=10) (Figure 31). 
 
Figure 31: Percentage distribution of the plasmid categorisation for the ST307 strain population (n=101) based on 
the total population (marked by the frame), presence of only R-M systems (n=91) and the absence of R-M 
systems (No system) (n=10). All the ST307 strains were CRISPR-Cas negative.  
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The group with only R-M systems had a total of 1% without any plasmids in contrast to the 
no-system group (9%). The proportion of strains with ≥ 2 plasmids was similar in the R-M 
(86%) and the non-system group (82%). The number of non-system strains (n=10) was too 
low to consider any statistical analysis.   
5.7 Sub analysis of dominant STs and high-risk STs 
Features of the dominant STs, high-risk hypervirulent- and MDR STs found in the carrier strain 
population, are listed in Table 8. Briefly, the most common ST20 (n=15) is considered a global 
high-risk MDR clone. However, all carrier ST20 strains were either AMR negative or non-
MDR. Only two strains had a virulence score 1. Moreover, sT26 (n=13) and ST35 (n=10), had 
an AMR negative profile and a total of two ST35 strains had acquired yersiniabactin. The 
plasmid content of all the dominant ST types was mostly from 2-3 plasmids and up, only one 
strain had only one plasmid (ST20). In terms of CRISPR-Cas systems, all ST20 strains were 
negative, all ST26 strains harboured Class 1 Type I-E and all ST35 contained Class 1 Type I-
E*. R-M systems were seen for the ST20 and ST26, in 15 of 28 strains with Type I (n=9) and 
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Table 8: Summary of features seen for the dominant-, globally associated high-risk hypervirulent- and MDR 
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*Also associated with globally spread high-risk MDR clones 
High-risk MDR associated ST types were seen in 33 carrier strains; ST20 (n=15) (one of the 
dominant ST types), ST70 (n=3), ST17 (n=3), ST29 (n=2), ST11 (n=1) and ST37 (n=9). 
However, only a total of two strains were MDR, the rest were AMR negative (n=29) or non-
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MDR (n=2). In terms of virulence factors, only five strains had acquired yersiniabactin, whereas 
the rest had no virulence factors. The plasmid content for these strains was diverse. The 
presence of CRISPR-Cas systems was only seen in ST11 (Class 1 Type I-E system). The 
presence of R-M systems was seen in 17 of the 33 strains.  
High-risk hypervirulent ST types (n=7) were seen in seven carrier strains: ST23 (n=1), ST375 
(n=1) and ST25 (n=5). However, virulence score 5 was only observed for the single ST23 strain. 
Moreover, four of the ST25 were also classified MDR. In terms of CRISPR-Cas systems, only 
ST23 were Class 1 Type I-E* positive and the rest were negative. However, R-M systems were 
found in six strains.  
Actual MDR genotypes was observed in 12 carrier strains, all non-ESBL; ST70 (n=1), ST25 
(n=4), ST17 (n=1), ST697 (n=1), ST3008 (n=1), (ST1693 (n=1) only 2 locus variants (LV) 
recognised), (ST499 (n=1) only one LV recognised), ST405 (n=1), and ST48 (n=1). Eleven 
strains were CRISPR-Cas negative, whereas one strain harboured CRISPR-Cas Class 1 Type 
I-E*. The distribution of R-M systems was: R-M negative (n=6), R-M Type IV (n=5, including 
co-occurrence), R-M Type I (n=2, including co-occurrence). A low virulence profile was 
observed in these strains: virulence score 0 (n= 6), virulence score 1 (n=6), plasmid content was 
diverse. 
Features of the dominant STs, high-risk hypervirulent- and MDR strains STs found in the 
NORM strain population, are listed in Table 9. Among the dominant ST types (n=90), ST20 
(n=17), ST37 (n=15), ST70 (n=14) and ST15 (n=13) are all ST types associated with high-risk 
MDR clones (n=59). Moreover, a total of 36 strains were classified as MDR and 34 were ESBL 
-producing strains. ST14 and ST45 in the dominant NORM STs displayed MDR (n=22) and 
ESBL (n=19). A total of 50 strains were virulence positive. 37 with virulence score 1, one strain 
with virulence score 3 and two strains with virulence score 4. A total 50 strains were CRISPR-
Cas negative, 31 were CRISPR-Cas Class 1 Type I-E* positive and 8 CRISPR-Cas Class 1 
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Table 9: Summary of features seen for the dominant-, globally associated high-risk hypervirulent- and MDR strains found in 
the NORM strain population.  
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Additionally, globally associated MDR high-risk ST strains, ST11 (n=4), ST17 (n=6) and 
ST29 (n=3) were also seen. These strains were classified as MDR (n=9) with co-occurring 
ESBL -production (n=4).  However, four strains were AMR negative. The virulence profile 
displayed virulence score 1 (n=5) and score 0 (n=8).  All strains were CRISPR-Cas negative, 
except for one ST11 with CRISPR-Cas Class 1 Type I-E. Only one strain (ST29) had a R-M 
system (Type I). The plasmid content was diverse. 
The global high-risk hypervirulent ST25 (n=6) and ST23 (n=2) were seen in the NORM strain 
collection. The ST25 strains had R-M system Type IV in five strains and no CRISPR-Cas 
systems. They displayed a low virulence profile with a virulence score 1 (n=5). The ST23 were 
CRISPR-Cas Class 1 Type I-E* positive and R-M Type III positive. Both ST23 strains had a 
virulence score 5 and were AMR negative.  
Some STs were commonly found in both carrier- and NORM strain populations. In total, 
the NORM strain collection represented the same global high-risk MDR ST types found in 
the carrier strains: ST70, ST17, ST29 and ST37. In terms of the rest of the profiles, they had 
many similarities like the absence of CRISPR-Cas systems.  
In addition to the globally MDR associated STs, there was also commonly associated 
hypervirulent high-risk ST types seen in both strain collections. The NORM strain collection 
harboured all the same known global high-risk hypervirulent strains, except for the ST375 
which were only seen in the carrier strains. The ST25 (n=6 NORM) displayed the same profiles 
being CRISPR-Cas negative and R-M positive between the strain populations. However, they 
were classified MDR in the NORM strain collection. For all ST23 in both collections, they were 
CRISPR-Cas Class 1 Type I-E*, but the carrier strain was R-M negative, while the NORM 
strains were R-M Type III positive, they were all classified with a virulence score 5. 
Other shared prevalent STs between carrier- and NORM strains have some general 
features in common. ST14 strains (n=25) were also found in both the carrier (n=7) and NORM 
(n=18) populations. All ST14 (n=25) were CRISPR-Cas Class 1 Type I-E* positive. The R-M 
system profile was diverse; R-M type I (n=9), R-M Type III (n=1, NORM), R-M Type IIG 
(n=1, carrier) or R-M negative (n=14). ST 14 had a low virulence profile; virulence negative 
(n=23). All carrier strains were AMR negative (n=7) whereas fifteen NORM strains were 
classified as MDR and eleven as ESBL -producing. ST35 (n=19) displayed an almost identical 
and profile for both the carrier (n=10) and NORM (n=9) strains. They had CRISPR-Cas systems 
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(n=18) and were R-M system negative. The differences amongst these strains were the NORM 
strains having 6 strains with virulence score 1, versus two in the carrier strains and one classified 
MDR in the NORM strain collection. ST26 (n=19) were found in 13 carrier strains and 6 
NORM strains. The ST26 had almost the same features, with CRISPR-Cas Class 1 Type I-E 
system and about half had presence of R-M systems (both populations). All had virulence score 
0, AMR negative (n=18), one non -MDR, all MDR negative with varying plasmid content.  
6 Discussion 
The aims in this study were to investigate the distribution of CRISPR-Cas- and R-M systems 
in different K. pneumoniae strain populations and their association to AMR -classification, 
virulence score and plasmid content. To achieve this, a large collection of human KpSC strains, 
previously characterized by WGS, was selected and examined thoroughly by various 
bioinformatic tools and statistical analyses. 
The strain collection consisted of faecal carrier strains from adults in the Tromsø 
municipality, clinical isolates (blood and urine) collected through the national NORM system 
and NORKAB study, as well as an international collection of ST307 strains. The ST307 
collection was selected as an interesting emerging high-risk MDR clone in Norway and 
abroad (1)(79)(75). The strain collection is quite large compared to previous studies of 
CRISPR-Cas/R-M systems distributions in K. pneumoniae (11)(51)(90)(91). The strain 
collection is also relevant and representative for the genetic diversity of K. pneumoniae strains 
circulating in the Norwegian human population. Population structure analysis of the carrier, 
NORM-ESBL and non-ESBL as well as ST307 revealed a total of 503 different ST types. A 
total of nine different ST types associated with high-risk clones were seen in the carrier and 
NORM collections. The ST307 also displayed diversity within the population and the strains 
had a variety of nationality. The plasmid content indicated a strong presence of 
INFIB(K)_1_Kpn3 (n=725), IncFII_1_pKp91 (n=548) and ColRNAI_1 (n=250) in all strain 
populations. Additionally, some plasmids, like Col(MGD2)_1 (n=35) was seen more 
frequently in the carrier- and NORM strain collections compared to the ST307. Whereas 
IncFiB(pQil)-1_pQil (n=24) was predominantly seen for the NORM ESBL- and ST307 
strains. However, there was a presence of 17% potential false positive nucleotide matches for 
the plasmid detection because of a mistake in the bioinformatic analysis.  
Bioinformatic identification of structurally complete CRISPR-Cas- and R-M systems was 
performed by screening the strains for CRISPR-Cas systems using CRISPRCasFinder and 
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manual assessment of the SimpleSynteny results. R-M system detection was performed using 
HMMer profiles. Only structural complete systems could possibly preform a biologic function, 
and therefore a lot of effort was put into this step. In addition to determining the presence, the 
CRISPR-Cas systems were classified using in-house profiles to determine their subtypes within 
the Class 1 Type I systems. Correspondingly, the R-M systems was also assessed by their types 
and subfamilies of MTases and REases to make sure they had potential to perform biological 
functions. It is fair to say that more programs were tested then what was found to be useful in 
producing results. In addition, many of the programs needed additional in-house profiles, 
adjustments and manual evaluation. The manual assessment led to discoveries in terms of 
potential mechanisms for CRISPR-Cas systems riddance. The results from assessing CRISPR-
Cas- and R-M systems will be further elaborated.  
Previous studies have documented a strong link between defined STs and their 
presence/absence of CRISP-Cas systems (11)(59)(90)(92). A similar strong association 
between defined STs and the presence or absence of CRISPR-Cas- and/or R-M systems was 
observed in this study for ST14, ST15, ST23 and ST307. The consistent relationship between 
defined STs and their CRISPR-Cas-/R-M systems content supports the quality of the 
bioinformatic work in detection of structural complete systems performed in this study. 
6.1 CRISPR-Cas systems: distribution and correlation to 
virulence score, AMR -classification and plasmid content  
Structurally complete CRISPR-Cas systems was found in 26% of the strains: carrier strains 
(30%), NORM non-ESBL strains (26%) and NORM ESBL strains (29%). Thus, the CRISPR-
Cas system seems to be equally distributed between faecal carrier and clinical strains. In 
contrast, a total absence of both structurally complete systems and fragmented CRISPR-Cas 
elements was observed in the ST307 population. 
A study in 2018, displayed a prevalence of 31% of CRISPR-Cas systems in clinical K. 
pneumoniae strains (n=176)(11). In the same study, they also documented the prevalence in 
publicly available K. pneumoniae  genomes to be 41% (11). One other study analysing the 
prevalence in publicly available databases has documented the prevalence to be 54% in 68 
Klebsiella genomes (51). Variations in the observed prevalence of CRISPR-Cas systems 
could be due to differences in strains collections and methods or criteria for systems 
identification. 
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Class 1 systems are the most commonly observed in K. pneumoniae (11)(51)(59). The 
subtype IV, I-E and the recent Type I-E* has been frequently seen in K. pneumoniae 
(11)(51)(59)(60). The study looking into both clinical and publicly available K. pneumoniae 
strains in 2018, displayed a total of 28% CRISPR-Cas Class 1 Type I-E (n=15) and 72% 
presence of Type I-E* (n=39) in the clinical strains, respectively (11). The distribution of 
Type I-E and I-E* systems were different in this study. The reason for this could be connected 
to the overrepresentation of ST23 (n=15) and ST15 (n=9), associated with Type I-E* in their 
study (11)(90). However, for the publicly available K. pneumoniae genomes (n=97) a total of 
58% were classified Type I-E and 43% Type I-E* (11). Similar distributions of CRISPR-Cas 
subsystems were seen in this study. In addition, a total of 1% (n=7) strains displaying co-
occurrence of CRISPR-Cas Class 1 Type I-E and I-E*. Co-occurrence of I-E and I-E* 
systems have to our knowledge not been previously reported and will be commented later. 
Some CRISPR-Cas subtypes have been assumed to be associated with certain MLST types 
(11)(90). A study of carbapenem-resistant K. pneumoniae revealed that ST11, ST45 and 
ST147 were associated with Type I-E and ST23, ST15, ST11, ST65 and ST685 with the Type 
I-E* (90). The results in this study also connected ST23 and ST15 to Type I-E* and ST11 and 
ST45 to Type I-E. Observations in this study are in line with previous reports showing ST-
specific patterns in the distribution of CRISPR-Cas systems including subtypes. 
6.1.1 Differences in virulence score, AMR-classification and plasmid 
content based on the presence and absence of CRISPR-Cas 
systems 
Comparison of all strains based on their CRISPR-Cas profile grouped by the absence of 
CRISPR-Cas (n=743), Type I-E positive (n=140), Type I-E* positive (n=109) and CRISPR-
Cas Class 1 Type I-E and I-E* positive (n=7), revealed groups specific features (11)(90). 
Overall, the strains without CRISPR-Cas systems seemed to have a lot in common with 
primarily the single subtypes I-E and I-E* groups. The strains with both subtypes displayed 
the most distant relationship to the strains with absence of CRISPR-Cas in the PCA analysis. 
CRISPR-Cas Class 1 Type I-E* strains have been associated with a lower susceptibility to 
ampicillin-sulbactam, cefazolin, cefuroxime and gentamicin, lower phage- an plasmid content 
compared to the I-E positive strains of K. pneumoniae (11). Resistance to the four classes of 
antibiotics would result in MDR classification in this study. Another study looking into 16 
virulence positive carbapenem-resistant K. pneumoniae, found the Type I-E* system to be 
associated with a higher virulence score compared to the strains with Type I-E or absence of 
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CRISPR-Cas (90). In this study, Type I-E* positive strains did not display significant higher 
prevalence of acquired virulence factors. Moreover, the prevalence of MDR was significant 
different between the Type I-E*compared to the absence of CRISPR-Cas systems. This was 
not consistent with previous studies (11)(90).  
There was a significant difference in the number of AMR negative strains between the strains 
without CRISPR-Cas and the presence of Type I-E*. CRISPR-Cas Type I-E strains 
displayed a higher susceptibility towards antimicrobial agents and a slightly increased 
virulence score possibly associated with the presence of ST11 and ST45. A study found ST45 
to be associated with CRISPR-Cas Class 1 Type I-E systems (11).  
A total of seven strains were positive for both CRISPR-Cas Class 1 Type I-E and I-E* 
subtypes. This has previously not been documented for K. pneumoniae, possibly because of 
limitations in the strain populations investigated. The biological function of harbouring both 
subtypes is today unknown and further studies are needed. The results in this study indicated 
the presence of features separating them from the other subtype-groups in the PCA analysis. 
The most interesting feature was all being AMR negative.  
Almost all CRISPR-Cas positive systems displayed a higher presence of acquired virulence 
factors. The combination of both systems displayed about the same profile compared to the 
CRISPR-Cas negative strains. The difference between virulence positive strains in Type I-E 
and I-E* was not significant. All the ST types in this study associated with high-risk 
hypervirulence harboured the I-E* subtype. And 77% of the strains with presence of virulence 
factors and CRISPR-Cas systems displayed presence of the I-E* subtype.  
6.2 Restriction- Modification systems: distribution and 
correlation to virulence score, AMR -classification and 
plasmid content 
R-M systems were found in 48% of the strains varying across populations; carrier (43%), 
NORM (44%) and ST307 (90%). Thus, the presence of R-M ysstems seems to be equally 
distributed between faecal carrier and clinical strains. There was significant difference 
between the prevalence of R-M systems and subtypes in the NORM ESBL- and ST307 
collections. This may well be due to ST- specific distributions of R-M systems and subtypes. 
Previous large studies have indicated an average of 2.1-2.6 R-M systems per prokaryote 
genome (63)(66). However, none of the studies focused on R-M systems in K. pneumoniae 
and both stated that the distribution could vary amongst bacterial genera and species (63)(66). 
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To our knowledge, there are no studies looking directly into the prevalence and function of R-
M systems in K. pneumoniae. However, the occurrence of R-M systems are found to be 
affected by the presence of MGEs, CRISPR-Cas systems, integrons and natural 
transformation (66). Previous studies have displayed rapid acquisition and loss of R-M 
primarily through HGT (63). In addition, some solitary R-M associated genes are transferred 
autonomously in small MEGs (66). 
The previous study by Oliveira et al. comprised 2261 prokaryotic genomes and stated the 
prevalence of R-M Types were the following: Type II (42%), Type I (30%), Type IV (29%) 
and Type III (8%) (66). The Type IIG is considered a subtype of Type III and is often not 
included in studies as they usually look into the most common types (63)(66). One interesting 
observation is that the Type I and Type IIG (total of 80% of R-M) are assumed to be almost 
impossible to avoid (61). Mechanisms like removal of recognition sites or expressions of R-M 
system inhibiting proteins, like Orc proteins, is rarely seen as a mechanism to avoid Type I 
systems (61). Type I is also connected to affect expression of certain genes which could give 
the host advantages, however these mechanisms are poorly understood (66). These features 
could be potentially useful for bacteria in environments with high selection pressures and in 
the presence of MGEs, but in need of limiting further acquisition of MGE affecting bacterial 
fitness, like the ST307. The high prevalence of Type I could potentially be explained by R-M 
systems ability to propagate themselves selfishly through HGT and their ability to select 
MGEs containing fragments of the present R-M Type (66). However, the specific functions of 
the different R-M Types in K. pneumoniae remains to be thoroughly investigated. 
Co-occurrence of R-M systems was observed in 12% for the R-M positive strains (n=488). 
The most common co-occurrence was Type I and Type IV (n=34). This co-occurrence was also 
significant in the Oliveira study (66). In addition to R-M system co- occurrence, there was also 
a significant association between R-M- and prevalence of CRISPR-Cas systems (66). CRISPR-
Cas related spacers do seldom target R-M systems (66). In this study, a total of 24% of the R-
M positive strains displayed a co-occurring CRISPR-Cas system.  
6.2.1 Differences in virulence score, AMR-classification and plasmid 
content based on the presence and absence of R-M systems 
Group analysis of strains with or without R-M systems indicated a large overlap between the 
two groups. Because of the large complexity of co-occurring systems, it was not considered 
beneficial to represent the individual systems and co-occurrences in a PCA plot. The R-M 
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positive strains were grouped into single- (one R-M system) (n=398) and multiple systems 
(more than one type of R-M system) (n=60). The PCA plot indicated overall differences 
between absence, single and multiple R-M systems.  
The group with absence of R-M systems displayed the highest virulence score and the 
lowest plasmid content. There was a significant difference in virulence negative strains 
between the R-M negative strains and the single R-M systems. A closer look at the virulence 
positive strains harbouring R-M systems revealed a prevalence of 55% R-M Type I and 26% 
R-M Type IV. These R-M types were also seen for some of the global MDR STs and the 
Type IV at the hypervirulent ST types. Presence of AMR -genes was found to be highest in 
the strains with single R-M systems. There was a significant difference in AMR negative 
strains between R-M negative strains and single R-M systems. One thing to note is that this 
population includes 90% of the ST307 MDR strains. Moreover, the R-M Type I was seen for 
81% of the R-M positive strains with MDR. R-M Type I system was also seen in some of the 
global high-risk MDR STs.  
The plasmid profiles displayed the highest plasmid content in the R-M positive strains. 
Interestingly, the strains with multiple R-M systems displayed the highest plasmid loads. 
They also displayed a significant difference in plasmid content ≥2 plasmids. This could 
potentially be because of the R-M systems stabilising the MGEs in the DNA with a high 
potentially because of R-M Type specific fragments in the plasmid (61)(63)(66).  
6.3 Co-occurrence of CRISPR-Cas- and R-M systems 
In total, 40% of the strains displayed absence of both systems, 12% contained both CRISPR-
Cas- and R-M systems, 14% showed only presence of CRISPR-Cas- and 34% R-M systems 
only. PCA analysis of the groups indicated similarities between the strains harbouring both 
CRISPR-Cas- and R-M systems compared to the strains with only CRISPR-Cas systems. 
These two groups had the most distant relationships to the strains with only R-M systems. 
The strains with complete absence of both CRISPR-Cas- and R-M systems had the average 
point of the population in between these systems.  
Absence of CRISPR-Cas- and R-M systems represented the situation unaffected by 
CRISPR-Cas- and R-M systems in the different strains. They had the second lowest virulence 
score by 1%. Looking at the resistance profile, this group had the second highest presence of 
MDR and ESBLs. There was no significant difference in the plasmid content ≥2 for this 
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group compared to the strains with only R-M systems. None of the dominant or high-risk 
clonal strains were included in this category.  
The strains only harbouring R-M systems previously displayed a significant difference in 
virulence negative strains compared to the R-M negative group. In this context, they also had 
the highest prevalence of virulence negative strains. This indicated that R-M systems had the 
highest association with virulence negative strains. Previous we also saw that there was a 
significant difference in AMR negative strains between the strains with no R-M systems and 
the ones with single R-M systems, indicating a potential association between AMR genes and 
R-M systems. Moreover, the analysis of only R-M systems also displayed a significant 
difference in harbouring ≥4 plasmids between the strains with absence of R-M systems and 
presence of multiple R-M systems. Here there was also a significant difference in carrying ≥4 
plasmids between the strains with R-M systems only and the strains with no system. In 
addition, there was a significant difference in carrying ≥4 plasmids between the strains only 
harbouring R-M systems and the strains with only CRISPR-Cas systems in the NORM ESBL 
strains. These observations suggests a significant association between presence of R-M 
system and higher plasmid load.  
The strains only harbouring CRISPR-Cas systems features displayed the highest 
percentage of strains with acquired virulence. Previously there was not proven a significance 
between the CRISPR-Cas Type I-E and I-E* with the highest numbers of virulence factors. 
However, the difference in virulence negative strains between strains with only CRISPR-Cas 
systems and the group without any system was significant. This observation suggests an 
association between the presence of CRISPR-Cas systems and a higher virulence score. The 
associations between a lower MDR profile for the group with absence of CRISPR-Cas 
compared to the CRISPR-Cas Type I-E* (second highest MDR profile) were significant. 
Here, they displayed the second lowest MDR profile, but there was no significance in AMR 
negative strains between the strains with only CRISPR-Cas systems and both CRIPSR-Cas- 
and R-M systems. In terms of plasmid content there was a significant difference in carrying 
≥2 plasmids between the group with only CRISPR-Cas- and only R-M systems. Moreover, 
there was a significant difference between plasmid content ≥4 plasmids between the CRISPR-
Cas systems and the R-M systems for the NORM ESBL strains. These observations underline 
a restrictive effect of CRISPR-Cas systems in terms of AMR genes and plasmid acquisition, 
but a possible association with higher virulence. 
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Analysis of the group with both CRISPR-Cas- and R-M systems indicated a significant 
difference between in virulence positive strains between the strains with only CRISPR-Cas- 
and the strains with both CRISPR-Cas- and R-M systems. The previously displayed 
significance in R-M systems restricting virulence factors seems to be in interplay with the 
CRISPR-Cas systems significant association with higher acquisition of virulence factors. 
There was also a significant difference in the presence of virulence factors between the strains 
only harbouring CRISPR-Cas systems and the strains with both CRISPR-Cas- and R-M 
systems. The AMR profile for these strains had the highest presence of AMR negative strains 
amongst all groups. There was no significant difference in the prevalence of AMR negative 
strains between the group with only CRISPR-Cas systems and the strains with both systems. 
There was a significant difference in AMR negative strains between the group with both 
systems and no systems. This indicated a restricting effect of CRISPR-Cas systems affecting 
the association of R-M systems to acquire AMR. Previously we saw the association of R-M 
systems and their higher plasmid content with a significant difference compared to the strains 
with only CRISPR-Cas systems. There was a significant lower prevalence in carriage of ≥4 
plasmids in the strains with both systems compared to the strains with only R-M systems, 
indicating the higher effect of CRISPR-Cas systems. This was supported by the absence of 
significant differences in carrying ≥4 plasmids between the group with both systems and the 
group with only CRISPR-Cas systems. 
6.4 Strengths and limitations  
This study has an overall strength because of the unique and large strain collection. The strain 
collections display diversity both within and between themselves. The carrier strains displayed 
common ST types as found in the NORM strain collection, representing the opportunistic 
pathogen side of K. pneumoniae. Moreover, there high-risk associated ST307 strains originated 
from Norway and additional countries with significant genetic diversity.  
The thorough assessment of the CRISPR-Cas- and R-M systems, allowed a certainty of the best 
prediction of potential functional systems. However, the complete systems can still be inactive 
because of self-targeting sequences (90).  
The weaknesses in this study are primarily represented the time limitations of a master’s degree. 
Learning bioinformatics and analysing a total of 999 strains sadly sets limits for how 
comprehensive the study can be. To make good conclusions and elaborate the potential 
relationships indicated in this study, it would have been useful to look into the spacers 
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specificity in the CRISPR-Cas systems, the phage content and do more advanced statistical 
analyses. Additionally, the PCA plots could have provided more information about the 
relationships of the results if they were not classified, but took in consideration the actual typing 
of plasmids, not just the categorised amounts. A potential mistake in plasmid detection 
procedure was detected late in this study. The homology cut off in the analysis was lacking 
because of word converting two double “-“ into one long, resulting in exclusion in the command 
line and no call back on the flag. This resulted in a total of ~17% of the plasmids hits in the 
study being below 80% homology and potential false positive results. The distribution of this 
mistake is divided 9.2% in the carrier-, 7.2% in the NORM- and 0.4% in the ST307 strain 
collections. 
7 Conclusions and future perspectives  
 The presence of CRISPR-Cas- and R-M systems seems to be prevalent and equally 
distributed in faecal carrier and clinical strains.  
 The content and distribution of CRISPR-Cas- and R-M systems, including subtypes, 
seems to have ST specific associations.  
 There was also some significant correlations between the presence and absence of 
CRISPR-Cas- and R-M systems in terms of MGE acquisition, reflected in virulence 
factors, AMR genes and plasmid content. These associations were seen across the 
strain collections.  
 CRISPR-Cas systems were associated with a higher virulence profile, a lower AMR 
and plasmid load. 
 The R-M systems were associated with lower virulence score, a higher AMR and 
plasmid load.  
 Future studies should include analysis of CRISPR spacer specificity, overall phage 






Page 82 of 109 
8 Citations 
1.  Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat 
Rev Microbiol [Internet]. 2020; Available from: http://dx.doi.org/10.1038/s41579-019-
0315-1 
2.  Lee CR, Lee JH, Park KS, Jeon JH, Kim YB, Cha CJ, et al. Antimicrobial resistance of 
hypervirulent Klebsiella pneumoniae: Epidemiology, hypervirulence-associated 
determinants, and resistance mechanisms. Front Cell Infect Microbiol. 2017;7(NOV).  
3.  Wyres KL, Holt KE. Klebsiella pneumoniae as a key trafficker of drug resistance genes 
from environmental to clinically important bacteria. Curr Opin Microbiol [Internet]. 
2018;45:131–9. Available from: https://doi.org/10.1016/j.mib.2018.04.004 
4.  Rettedal S, Löhr IH, Natås O, Giske CG, Sundsfjord A, Øymar K. First outbreak of 
extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Norwegian 
neonatal intensive care unit; associated with contaminated breast milk and resolved by 
strict cohorting. Apmis. 2012;120(8):612–21.  
5.  Dalgleish T, Williams JMG., Golden A-MJ, Perkins N, Barrett LF, Barnard PJ, et al. 
Klebsiella pneumoniae- En nasjonal studie ac sykdomsbyrde, populasjonsstruktur, 
resistensutvikling og virulens hos en stadig viktigere humanpatogen. 2007. p. 1–10.  
6.  Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic 
perspective. Infect Ecol Epidemiol. 2014;4(1).  
7.  Tacconelli E et al. Global Priority List of Antibiotic-Resistant Bacteria to Guide 
Research, Discovery, and Development of New Antibiotics. World Health 
Organisation Global priority list of antibiotic-resistant bacteria to guide research, 
discovery, and development of new antibiotics. 2017.  
8.  Wyres KL, Wick RR, Judd LM, Froumine R, Tokolyi A, Gorrie CL, et al. Distinct 
evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones 
of Klebsiella pneumoniae. PLoS Genet. 2019;15(4):e1008114.  
9.  Koonin E V., Makarova KS, Zhang F. Diversity, classification and evolution of 
CRISPR-Cas systems. Curr Opin Microbiol [Internet]. 2017;37:67–78. Available from: 
http://dx.doi.org/10.1016/j.mib.2017.05.008 
 
Page 83 of 109 
10.  Shen J, Li L, Wang X, Xiu Z, Chen G. Comparative analysis of CRISPR-Cas systems 
in Klebsiella genomes. J Basic Microbiol. 2017;57:325–36.  
11.  Li HY, Kao CY, Lin WH, Zheng PX, Yan JJ, Wang MC, et al. Characterization of 
CRISPR-Cas systems in clinical Klebsiella pneumoniae isolates uncovers its potential 
association with antibiotic susceptibility. Front Microbiol. 2018;9(JUL):1–9.  
12.  Adeolu M, Alnajar S, Naushad S, Gupta RS. Genome-based phylogeny and taxonomy 
of the ‘Enterobacteriales’: Proposal for enterobacterales ord. nov. divided into the 
families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., 
Yersiniaceae fam. nov., Hafniaceae fam. nov., Morgane. Int J Syst Evol Microbiol. 
2016;66(12):5575–99.  
13.  Barbier E, Rodrigues C, Depret G, Passet V, Gal L, Piveteau P, et al. The ZKIR Assay, 
a Real-Time PCR Method for the Detection of Klebsiella pneumoniae and Closely 
Related Species in Environmental Samples. Appl Environ Microbiol. 2020;86(7):1–15.  
14.  Ludden C, Moradigaravand D, Jamrozy D, Gouliouris T, Blane B, Naydenova P, et al. 
A One Health Study of the Genetic Relatedness of Klebsiella pneumoniae and Their 
Mobile Elements in the East of England. Clin Infect Dis. 2019;(Xx):1–8.  
15.  Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. 
Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 
2013;13(12):1057–98.  
16.  Gorrie CL, Mirc Eta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, et al. 
Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in 
Intensive Care Patients. Clin Infect Dis. 2017;65(2):208–15.  
17.  Lin YT, Siu LK, Lin JC, Chen TL, Tseng CP, Yeh KM, et al. Seroepidemiology of 
Klebsiella pneumoniae colonizing the intestinal tract of healthy chinese and overseas 
chinese adults in Asian countries. BMC Microbiol. 2012;12.  
18.  Raffelsberger N, Andrea M, Hetland K, Andreassen L, Gravningen K, Löhr H, et al. 
P1772 Human gut carriage of Klebsiella pneumoniae in an adult community 
population-ECCMID poster. 2019.  
 
Page 84 of 109 
19.  Blin C, Passet V, Touchon M, Rocha EPC. Metabolic diversity of the emerging 
pathogenic lineages of Klebsiella pneumoniae. Environ Microbiol. 2017;19(5):1881–
98.  
20.  Leadbetter ER. Microbiology, an Evolving Science [Internet]. 4th editio. Twitchell B, 
editor. Vol. 4, Microbe Magazine. London, England: Norton & Company; 2009. 236–
354 p. Available from: hhps://lccn.loc.gov/2016051604 
21.  Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing 
of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8):4178–82.  
22.  Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, 
et al. Genomic definition of hypervirulent and multidrug-resistant klebsiella 
pneumoniae clonal groups. Emerg Infect Dis. 2014;20(11):1812–20.  
23.  Dupuis MÈ, Villion M, Magadán AH, Moineau S. CRISPR-Cas and restriction-
modification systems are compatible and increase phage resistance. Nat Commun. 
2013;4(May):1–7.  
24.  Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, et 
al. Redefining extended-spectrum β-lactamases: Balancing science and clinical need. J 
Antimicrob Chemother. 2009;63(1):1–4.  
25.  Fostervold A, Raffelsberger N, Andrea M, Hetland K, Bernhoff E, Sundsfjord A, et al. 
Klebsiella pneumoniae ST107 : an emerging invasive clone in Norway -ECCMID 
poster. Vol. 29 th ECCM. 2019.  
26.  Villa L, Feudi C, Fortini D, Brisse S, Passet V, Bonura C, et al. Diversity, virulence, 
and antimicrobial resistance of the KPCproducing klebsiella pneumoniae ST307 clone. 
Microb Genomics. 2017;3(4).  
27.  García-Martínez J, Maldonado RD, Guzmán NM, Mojica FJM. The CRISPR 
conundrum: Evolve and maybe die, or survive and risk stagnation. Microb Cell. 
2018;5(6):262–8.  
28.  Rossolini GM, D’Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-
spectrum β-lactamases. Clinical Microbiology and Infection. 2008.  
 
Page 85 of 109 
29.  Rezazadeh M, Baghchesaraei H, Peymani A. Plasmid-Mediated Quinolone-Resistance 
(qnr) Genes in Clinical Isolates of Escherichia coli Collected from Several Hospitals of 
Qazvin and Zanjan Provinces, Iran. Osong Public Heal Res Perspect [Internet]. 
2016;7(5):307–12. Available from: http://dx.doi.org/10.1016/j.phrp.2016.08.003 
30.  Peirano G, Pitout JDD. Extended-Spectrum β-Lactamase-Producing 
Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options. 
Drugs. 2019;79(14):1529–41.  
31.  Samuelsen Ø. ESBL-A ESBL-M -Høstkonferansen. Nasjonal kompetansetjeneste for 
påvisning av antibiotikaresistens (K-res); 2018.  
32.  Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schønning K, et al. 
Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli 
and Klebsiella pneumoniae: Prevalence, β-lactamase distribution, phylogroups, and co-
resistance. Scand J Infect Dis. 2012;44(3):174–81.  
33.  Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. 
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An 
international expert proposal for interim standard definitions for acquired resistance. 
Clin Microbiol Infect [Internet]. 2012;18(3):268–81. Available from: 
http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x 
34.  Naseer U, Sundsfjord A. The CTX-M Conundrum: Dissemination of Plasmids and 
Escherichia coli Clones. Microb Drug Resist [Internet]. 2011;17(1):83–97. Available 
from: http://www.liebertonline.com/doi/abs/10.1089/mdr.2010.0132 
35.  Shon AS, Bajwa RPS, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella 
Pneumoniae: A new and dangerous breed. Virulence. 2013;4(2):107–18.  
36.  Bush K, Fisher JF. Epidemiological Expansion, Structural Studies, and Clinical 
Challenges of New β-Lactamases from Gram-Negative Bacteria. Annu Rev Microbiol 
[Internet]. 2011;65(1):455–78. Available from: 
http://www.annualreviews.org/doi/10.1146/annurev-micro-090110-102911 
37.  Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, et al. A fatal outbreak of ST11 
carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a 
 
Page 86 of 109 
molecular epidemiological study. Lancet Infect Dis [Internet]. 2018;18(1):37–46. 
Available from: http://dx.doi.org/10.1016/S1473-3099(17)30489-9 
38.  Paczosa MK, Mescas J. Klebsiella pneumoniae : Going on the Offense with a Strong 
Defense. Microbiol Mol Biol Rev. 2016;80(3):629–61.  
39.  Follador R, Heinz E, Wyres KL, Ellington MJ, Kowarik M, Holt KE, et al. The 
diversity of Klebsiella pneumoniae surface polysaccharides. Microb genomics. 
2016;2(8):e000073.  
40.  Gomez-Simmonds A, Uhlemann AC. Clinical implications of genomic adaptation and 
evolution of carbapenem-resistant klebsiella pneumoniae. J Infect Dis. 2017;215(Suppl 
1):S18–27.  
41.  Lam MMC, Wick RR, Wyres KL, Gorrie CL, Judd LM, Jenney AWJ, et al. Genetic 
diversity, mobilisation and spread of the yersiniabactin-encoding mobile element 
ICEKp in Klebsiella pneumoniae populations. Microb genomics. 2018;4(9).  
42.  Löhr IH, Rettedal S, Natås OB, Naseer U, Øymar K, Sundsfjord A. Long-term faecal 
carriage in infants and intra-household transmission of CTX-M-15-producing 
Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother. 
2013;68(5):1043–8.  
43.  Martin RM, Cao J, Brisse S, Passet V, Wu W, Zhao L, et al. Molecular Epidemiology 
of Colonizing and Infecting Isolates of Klebsiella. Clin Sci Epidemiol. 2016;1(5):1–12.  
44.  Thomas CM, Nielsen KM. Mechanisms of, and barriers to, horizontal gene transfer 
between bacteria. Nat Rev Microbiol. 2005;3(9):711–21.  
45.  Kamruzzaman M, Iredell JR. CRISPR-Cas System in Antibiotic Resistance Plasmids 
in Klebsiella pneumoniae. Front Microbiol. 2020;10(January).  
46.  De la Cruz F, Davies J. Horizontal gene transfer and the origin of species: Lessons 
from bacteria. Trends in Microbiology. 2000.  
47.  McDonald ND, Regmi A, Morreale DP, Borowski JD, Fidelma Boyd E. CRISPR-Cas 
systems are present predominantly on mobile genetic elements in Vibrio species. BMC 
Genomics. 2019;20(1):1–23.  
 
Page 87 of 109 
48.  Ramirez MS, Iriarte A, Reyes-Lamothe R, Sherratt DJ, Tolmasky ME. Small 
Klebsiella pneumoniae Plasmids: Neglected Contributors to Antibiotic Resistance. 
Front Microbiol. 2019;10(September):1–14.  
49.  Carattoli A, Zankari E, Garciá-Fernández A, Larsen MV, Lund O, Villa L, et al. In 
Silico detection and typing of plasmids using plasmidfinder and plasmid multilocus 
sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–903.  
50.  Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity 
in bacteria and archaea. Nat Rev Genet. 2010;11(March):181–90.  
51.  Shen J, Lv L, Wang X, Xiu Z, Chen G. Comparative analysis of CRISPR-Cas systems 
in Klebsiella genomes. J Basic Microbiol. 2017;57(4):325–36.  
52.  Faure G, Shmakov SA, Yan WX, Cheng DR, Scott DA, Peters JE, et al. CRISPR–Cas 
in mobile genetic elements: counter-defence and beyond. Nat Rev Microbiol [Internet]. 
2019;17(8):513–25. Available from: http://dx.doi.org/10.1038/s41579-019-0204-7 
53.  Krebs , Jocelyn E Goldstein, Elliott S Kilpatrick ST. Lewin`s Genes XII. Kane, 
Matthew Schwinn, Audrey Hoffman NHN, editor. Burlington, Massachusetts; 2018. 
769–780 p.  
54.  Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, et al. An 
updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 
2015;13(11):722–36.  
55.  Gholizadeh P, Aghazadeh M, Asgharzadeh M, Kafil HS. Suppressing the CRISPR/Cas 
adaptive immune system in bacterial infections. Eur J Clin Microbiol Infect Dis. 
2017;36(11):2043–51.  
56.  Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS, Brouns SJJ, et al. 
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived 
variants. Nat Rev Microbiol. 2019;  
57.  Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Horvath P, et al. 
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol. 
2011;9(6):467–77.  
 
Page 88 of 109 
58.  Makarova KS, Wolf YI, Koonin E V. Classification and Nomenclature of CRISPR-Cas 
Systems: Where from Here? Cris J. 2018;1(5):325–36.  
59.  Mackow NA, Shen J, Adnan M, Khan AS, Fries BC, Diago-Navarro E. CRISPR-Cas 
influences the acquisition of antibiotic resistance in Klebsiella pneumoniae. PLoS 
ONE2 [Internet]. 2019;14(11):13. Available from: 
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0225131 
60.  Newire E, Aydin A, Juma S, Enne VI, Roberts AP, Free R, et al. Identification of a 
Type IV CRISPR-Cas system located exclusively on IncHI1B/IncFIB plasmids in 
Enterobacteriaceae. 2019.  
61.  Rusinov IS, Ershova AS, Karyagina AS, Spirin SA, Alexeevski A V. Avoidance of 
recognition sites of restriction-modification systems is a widespread but not universal 
anti-restriction strategy of prokaryotic viruses. BMC Genomics. 2018;19(1):1–11.  
62.  Wilson GG, Murray NE. Restriction and modification systems. Annu Rev Genet. 
1991;25:585–627.  
63.  Ershova AS, Rusinov IS, Spirin SA, Karyagina AS, Alexeevski A V. Role of 
restriction-modification systems in prokaryotic evolution and ecology. Biochem. 
2015;80(10):1373–86.  
64.  Pleška M, Guet CC. Effects of mutations in phage restriction sites during escape from 
restriction–modification. Biol Lett. 2017;13(12):10–3.  
65.  Shen BW, Xu D, Chan SH, Zheng Y, Zhu Z, Xu SY, et al. Characterization and crystal 
structure of the type IIG restriction endonuclease RM.BpuSI. Nucleic Acids Res. 
2011;39(18):8223–36.  
66.  Oliveira PH, Touchon M, Rocha EPC. The interplay of restriction-modification 
systems with mobile genetic elements and their prokaryotic hosts. 2014;42(16):10618–
32.  
67.  Wang X, Liotta L. Clinical bioinformatics: A new emerging science. J Clin 
Bioinforma. 2011;1(1):2–4.  
68.  illumina. A high-resolution view of the genome [Internet]. Available from: 
 
Page 89 of 109 
https://www.illumina.com/techniques/sequencing/dna-sequencing/whole-genome-
sequencing.html 
69.  Inouye M, Dashnow H, Raven LA, Schultz MB, Pope BJ, Tomita T, et al. SRST2: 
Rapid genomic surveillance for public health and hospital microbiology labs. Genome 
Med. 2014;6(11):1–16.  
70.  Sczyrba A. Critical Assessment of Metagenome Interpretation- a benchmark of 
computational metagenomics software. Nat Methods. 2017;14(11):163–78.  
71.  UiT NAU. Den sjuende Tromsø-undersøkelsen (Tromsø 7). [Internet]. Available from: 
https://uit.no/forskning/forskningsgrupper/sub?p_document_id=367276&sub_id=5037
78 
72.  Rafaelsberger N et. al. unpublished.  
73.  Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCAST disk diffusion 
antimicrobial susceptibility testing method and its implementation in routine 
microbiology laboratories. Clin Microbiol Infect [Internet]. 2014;20(4):O255–66. 
Available from: http://dx.doi.org/10.1111/1469-0691.12373 
74.  EUCAST. EUCAST- The European Committee on Antimicrobial Susceptibility 
Testing. Breakpoint tables fon interpreation of MICs and zone diameters. [Internet]. 
Available from: http://www.eucast.org 
75.  Hetland M et al. unpublished.  
76.  NORM - Norsk overvåkingssystem for antibiotikaresistens hos mikrober [Internet]. 
Available from: https://unn.no/fag-og-forskning/norm-norsk-overvakingssystem-for-
antibiotikaresistens-hos-mikrober 
77.  Fostervold A et al. unpublished.  
78.  Fostervold A. The Norwegian Klebsiella pneumonia bacteremia study. Reg Kom Med 




Page 90 of 109 
79.  Fostervold A. The Norwegian Klebsiella pneumoniae bacteremiae study. 2016;(12):1–
12.  
80.  ENA. ENA-European Nucleotide Archive [Internet]. Available from: 
https://www.ebi.ac.uk/ena 
81.  Wick R, Whyres K, Holt KE. Kleborate github [Internet]. Australia; 2018. Available 
from: https://github.com/katholt/Kleborate#klebsiella-species 
82.  Institut Pasteur MLST and whole genome MLST databases. Primers used for MLST og 
Klebsiella pneumoniae [Internet]. Available from: 
https://bigsdb.pasteur.fr/klebsiella/primers_used.html 
83.  Martin C J, Maiden MJ, Rensburg J van, Bray JE, Earle SG, Ford SA, et al. MLST 
revisited: the gene-by-gene approach to bacterial genomics. Nat Rev Microbiol. 
2013;11(10):728–36.  
84.  Carattoli A, Zankari E, Garciá-Fernández A, Larsen MV, Lund O, Villa L, et al. 
PlasmidFinder and pMLST: In Silico detection and typing of plasmids using 
plasmidfinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 
2014;58(7):3895–903.  
85.  Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: 
Rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691–
3.  
86.  Alkhnbashi OS, Meier T, Mitrofanov A, Backofen R, Voß B. CRISPR-Cas 
bioinformatics. Methods [Internet]. 2019;(July):1–9. Available from: 
https://doi.org/10.1016/j.ymeth.2019.07.013 
87.  CRISPRCasFinder / CRISPRCasViewer manual [Internet]. 2019. p. 1–9. Available 
from: https://github.com/dcouvin/CRISPRCasFinder 
88.  Couvin D, Bernheim A, Toffano-Nioche C, Touchon M, Michalik J, Néron B, et al. 
CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced 
performance and integrates search for Cas proteins. Nucleic Acids Res. 
2018;46(W1):W246–51.  
 
Page 91 of 109 
89.  Kassambara A. A practical Guide To Principal Component Methods in R [Internet]. 
STHDA-Statistical tools for high-throughput data analysi. 2017. Available from: 
http://www.sthda.com/english/articles/31-principal-component-methods-in-r-practical-
guide/112-pca-principal-component-analysis-essentials/ 
90.  Liu Y, Chen C, Li J, Du F, Long D, Zhang W, et al. Distribution of CRISPR-Cas 
Systems in Clinical Carbapenem-Resistant Klebsiella pneumoniae Strains in a Chinese 
Tertiary Hospital and Its Potential Relationship with Virulence. Microb Drug Resist. 
2019;00(00):1–7.  
91.  Lin TL, Pan YJ, Hsieh PF, Hsu CR, Wu MC, Wang JT. Imipenem represses CRISPR-
Cas interference of DNA acquisition through H-NS stimulation in Klebsiella 
pneumoniae. Sci Rep [Internet]. 2016;6(July):1–10. Available from: 
http://dx.doi.org/10.1038/srep31644 
92.  Tang Y, Fu P, Zhou Y, Xie Y, Jin J, Wang B, et al. Absence of the type I-E CRISPR-
Cas system in Klebsiella pneumoniae clonal complex 258 is associated with 
dissemination of IncF epidemic resistance plasmids in this clonal complex. J 











Page 92 of 109 
Appendix 1: Bioinformatic command lines 
## Downloading strains from ENA using https://github.com/stevenjdunn/enaget  
$ python path/to/enaget -l path/to/list.txt -o downloadedENA $ 
##Annotation and removal of contigs below 200nt by Prokka using 
https://github.com/tseemann/prokka 
$ for F in *.fasta; do N=$(basename $F .fasta) ; prokka --prefix "$F" --locustag "$F" --cpus 
70 --usegenus --compliant --mincontiglen 200 --genus Klebsiella --species pneumoniae --
outdir "$F"_prokka --force --addgenes $F; done $ 
##Assembly 
#Assembly was done using https://github.com/marithetland/Asmbl, the commands and 
parameters for trimming and assmbly are: 
#TrimGalore 
$ trim_galore --paired -trim1 --retain_unpaired Sequence_?.fastq.gz # Outputs 
Sequence_1_val_1.fq.gz and Sequence_2_val_2.fq $ 
#Unicycler: 
$ unicycler -1 Sequence_1_val_1.fq.gz -2 Sequence_2_val_2.fq.gz -o Sequence_assembly --
verbosity 2 --keep 2 $ 
##Kleborate using https://github.com/katholt/Kleborate.git 
$ kleborate -r --all -a *.fasta $ 
##Plasmidfinder through abricate (https://github.com/tseemann/abricate) 
$ for file in *.fasta ; do abricate --db plasmidfinder -- mincov 80 -- minid 80 $file > 
${file}_abricate.tsv ; done $ 
$ abricate --summary *.tsv >summary_Abricate.tsv $ 
##Phylogenetic tree by Roary 
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$roary -n -e --mafft -p 64 Gff_Files_ST307/*.gff 
create_pan_genome_plots.R *.Rtab 
roary_plots.py --labels accessory_binary_genes.fa.newick gene_presence_absence.csv $ 
##Running CRISPRCasFinder 
$ for file in $(ls *fasta); do 
~/Klebs_project/Programs/CRISPRCasFinder/CRISPRCasFinder.pl -html -copyCSS -cas -
minDR 19 -minSP 20 -def SubTyping -getSummaryCasfinder -so 
~/Klebs_project/Programs/CRISPRCasFinder/sel392v2.so  -ccvr -in $file ; done $ 
##BLAST using https://anaconda.org/bioconda/blast 
$; for x in *.fasta; do blastn -query $x -db Merged_Cas1_Ref.fa -outfmt 6 -out $x.BCas1.tsv; 
done $ 
## Structural evaluation and subtyping by SimpleSynteny using   
https://www.dveltri.com/simplesynteny/about.html 
$ for F in *.fa do N=$(basename $F *.fa); ~/SimpleSyntheny/SyntenyMapper.rb I-
ES_Merged.fasta $F $F.out -e 0.001 -cov 80 ; done $ 
##R-M system profile by HMMER using https://github.com/EddyRivasLab/hmmer 
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Appendix 2: SimpleSynteny evaluation 
 
Carrier strains  
Type I-E 80% coverage  
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CRISPR-Cas Type I-E*  
 
 
Page 99 of 109 
 
Page 100 of 109 
 
Page 101 of 109 
 
 
NORM strain collection 
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CRISPR-Cas Class 1Type I-E 
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CRISPR-Cas Class 1Type I-E*  
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